{"title":"Local Coverage Determination (LCD): Cardiology � non-emergent outpatient testing: exercise stress test, stress echo, MPI SPECT, and cardiac PET (L36209)","lcdInfo":{"lcd_id":36209,"lcd_version":15,"display_id":null,"title":"Cardiology � non-emergent outpatient testing: exercise stress test, stress echo, MPI SPECT, and cardiac PET","determination_number":null,"cms_cov_policy":"<p>Language quoted from CMS National Coverage Determination (NCDs) and coverage provisions in interpretive manuals are italicized throughout the Local Coverage Determination (LCD). NCDs and coverage provisions in interpretive manuals are not subject to the LCD Review Process (42 CFR 405.860[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See &sect;1869(f)(1)(A)(i) of the Social Security Act.<br /><br />Unless otherwise specified, <em>italicized text </em>represents quotation from one or more of the following CMS sources:<br /><br />Medicare National Coverage Determinations Manual, Pub. 100-03, Chap. 1, Part 4, Sections 220.12, 220.5, 220.6, 220.6.1, and 220.6.8<br /><br />Medicare Claims Processing Manual, Pub. 100-04, Chap. 13, Section 60.2.1, 60.3.2, 60.4</p>","orig_det_eff_date":"2015-10-01T00:00:00.000Z","ent_det_end_date":null,"rev_eff_date":"2017-10-01T00:00:00.000Z","rev_end_date":null,"indication":"<p>Noninvasive testing in the outpatient setting to assess coronary artery disease (CAD) and left ventricular (LV) dysfunction may be accomplished utilizing conventional exercise testing or by measuring the distribution of nuclear medicine reagents during physiologic or pharmacologic stress.<br /><br />Cardiovascular stress testing, also called an exercise stress test (EST), exercise electrocardiogram, exercise treadmill test (ETT), graded exercise test, or stress electrocardiogram (ECG), is used to provide information about how the heart responds to exertion. It usually involves walking on a treadmill or pedaling a stationary bike at increasing levels of difficulty, while the electrocardiogram, heart rate, and blood pressure are monitored. The same measurement may be obtained with the substitution of echocardiography for a standard ECG. Echocardiography is used to image cardiac structures and function and also flow direction and velocities within cardiac chambers and vessels. Usually these images are obtained from several positions on the chest wall and abdomen using a hand-held transducer.<br /><br />In many instances, exercise testing (without imaging) may be combined with imaging procedures, such as myocardial perfusion imaging, radionuclide ventriculography, echocardiography, or other imaging procedures.<br /><br />There are 3 principle types of stress tests which do not involve the measurement of radio-labelled distribution within the body. These include:<br /><br />&bull; Exercise stress test (EST) is normally the first stress test performed. The patient walks on a treadmill or similar device while being monitored to measure endurance with an end-point of symptoms, ECG, or echocardiographic changes that suggest coronary under-perfusion. EST is without imaging. An EST must include an ECG that can be interpreted for ischemia, and the patient must be capable of exercise on a treadmill or similar device generally at 4 METs or greater (i.e., able to walk four blocks without stopping, can climb two flights of stairs without stopping). An abnormal EST includes any one of the following: ST segment depression, development of chest pain, significant arrhythmia (especially ventricular arrhythmia), or hypotension.<br /><br />&bull; Dobutamine, Dipyridamole, or Adenosine Stress Test is used in people who are unable to exercise. A drug is given to make the heart respond as if the person were exercising. This way the doctor can still determine how the heart responds to stress, but no exercise is required.<br /><br />&bull; Stress echocardiogram is a graphic outline of the heart's movement. A stress echo can accurately visualize the motion of the heart's walls and pumping action when the heart is stressed; it may reveal a lack of blood flow that isn't always apparent on other heart tests.<br /><br />The main task of Nuclear Cardiology and Nuclear Medicine is not the representation of anatomy, as in traditional Diagnostic Radiology; rather, it is the non-invasive visualization of functional, metabolic processes. In diagnostic Nuclear Medicine, the subject first incorporates tracer amounts of a radioactively-labelled molecule. Once the tracer molecule is properly distributed inside the body, imaging techniques visualize the metabolism of the substance by measuring the distribution of the radioactively-labelled molecule through externally emitted radiation. <br /><br />Myocardial perfusion imaging (MPI) SPECT is a cardiac radionuclide imaging procedure that evaluates blood flow to the cardiac muscle. MPI is usually performed with exercise ECG testing for detecting coronary artery disease and determining prognosis using a gamma camera to record images in planar or tomographic (single photon emission computed tomography) (SPECT) projections. Use of dual radiopharmaceuticals permits concurrent studies at rest and after stress, which is then compared and interpreted by a nuclear physician. Since the radiopharmaceutical accumulates in the myocardium in relation to blood flow, ischemic and infarcted myocardium can be detected. The specific imaging technique (perfusion versus ventricular function) and the reason for the imaging determines what radionuclide agent is employed. A perfusion study utilizes an imaging isotope agent that reflects myocardial blood flow and, dependent on the agent and timing of image acquisition, the presence of scar and/or ischemia. Ventricular function studies utilize specific imaging isotopes to outline the borders of the left ventricular endocardium or to identify the ventricular blood pool independent of the surrounding myocardium. The motion of the left ventricle is synchronized with the electrocardiogram to generate wall motion and ejection fraction information. In instances where an exercise test cannot be performed, Dipyridamole, Adenosine, Dobutamine or other provocative agents may be used to alter coronary flow, thereby unmasking a suspected lesion in the coronary bed. <br /><br />Cardiac PET (positron emission tomography) myocardial perfusion imaging is another cardiac radionuclide imaging procedure in which radioactive tracers are used to diagnose patients with suspected coronary artery disease (CAD) and provide important risk stratification of patients with known CAD. This test is also a valuable tool to assess myocardial viability, myocardial wall motion and ejection fraction, as well as, cardiac sarcoidosis. For diagnosis, radionuclides are administered intravenously and distribute in proportion to the regional myocardial blood flow present at the time of injection. In selected patients, cardiac PET offers certain advantages over standard of care Single Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT MPI). Cardiac PET is a useful technique that allows a noninvasive evaluation of myocardial blood flow, function, and metabolism, using physiological substrates prepared with positron-emitting radionuclides, such as oxygen, nitrogen, fluorine, and rubidium. These radionuclides have half-lives that are considerably shorter than those used in SPECT. Positron-emitting radionuclides are produced either using a cyclotron, such as fluoro-2-deoxyglucose (F-18 FDG) with a 110-minute half-life, or nitrogen-13-ammonia (N-13), with a half-life of 9.8 minutes or a generator such as rubidium-82 (Rb-82) with a 75-second half-life. Because of availability, the most common PET blood flow tracer is rubidium-82. The goal of cardiac PET perfusion imaging is to detect physiologically significant coronary artery narrowing. Results of the test should lead toward risk factor modification in order to delay or reverse the progression of atherosclerosis, alleviate symptoms of ischemia, and improve patient survival by either medical therapy or revascularization procedures such as bypass surgery (CABG) or percutaneous coronary intervention (PCI). Stress and rest paired myocardial perfusion studies are commonly performed to assess myocardial ischemia and/or infarction. Current Food and Drug Administration (FDA)-approved and Centers for Medicare and Medicaid Services-covered PET myocardial blood flow tracers are limited to Rb-82, F-18 FDG, and N-13 ammonia. Normal MPI implies the absence of significant CAD. Abnormal myocardial perfusion on stress imaging suggests the presence of significantly narrowed coronary arteries. If the stress regional perfusion defect is absent on the corresponding rest images, it suggests the presence of stress-induced myocardial ischemia. If the stress perfusion defect persists at rest, it suggests prior infarction. Imaging of myocardial perfusion can also be combined with myocardial metabolism imaging with F-18FDG for the assessment of myocardial viability in areas of resting hypoperfusion and dysfunctional myocardium. The stress protocols are, for the most part, similar for all cardiac PET perfusion agents. The specific differences in acquisition protocols for Rb-82 and N-13 are related to the duration of uptake and clearance of these radiopharmaceuticals and their physical half-lives.<br /><br /><strong><u>Indications:</u><br /><br />A cardiovascular stress test (pharmacologic and non-pharmacologic) will be considered medically reasonable and necessary for the following conditions: </strong><br /><br /><u> Stress Testing without Imaging:</u> For the diagnosis of suspected and prognosis of coronary artery disease in patients with normal or minor changes in resting ECG and no contraindications to exercise.<br /><br /><u> Stress Testing with Imaging:</u><br /><br />Imaging stress tests addressed in this LCD include stress echocardiography and SPECT or PET nuclear myocardial perfusion imaging (MPI).<br /><br />Stress testing with imaging can be performed with maximal exercise or chemical stress (dipyridamole, dobutamine, adenosine or adenosine analogs). <br /><br />Stress echo and SPECT MPI are considered equivalent diagnostic tests. However, in addition to myocardial ischemia, stress echo can provide additional information that is not obtainable with MPI, such as valve function, assessment of pulmonary pressure, and assessment of dynamic obstruction. The most commonly performed myocardial perfusion imaging are single (at rest or stress, CPT code 78451) and multiple (at rest and stress, CPT code 78452) tomographic SPECT studies. Evaluation of the individual&rsquo;s left ventricular wall motion and ejection fractions are routinely performed during SPECT MPI and are included in the code&rsquo;s definition. Attenuation correction, when performed, is included in the MPI service.<br /><br />When symptoms are present, and there is sufficient suspicion of heart disease to warrant cardiac evaluation, it is expected that the provider make a probability estimate of the likelihood of CAD prior to selecting testing. Assessment of coronary artery disease can be determined by the following:<br /><br /><u> Typical angina (definite):</u> Substernal chest pain or discomfort that is provoked by exertion or emotional stress and relieved by rest and/or nitroglycerin.<br /><br /><u> Atypical angina (probable): </u>Chest pain or discomfort (arm or jaw pain) that lacks one of the characteristics of definite or typical angina. <br /><br /><u> Non-anginal chest pain: </u>Chest pain or discomfort that meets one or none of the typical angina characteristics.<br /><br /><u> Anginal variants or equivalents:</u> A manifestation of myocardial ischemia, which is perceived by patients to be (otherwise unexplained) dyspnea, unusual fatigue, more often seen in women and may be unassociated with chest pain.<br /><br />Age, gender, and the character of the chest pain provide useful predictors of CAD. Refer to the following table for cardiac imaging guidelines.<br /><br /><strong> Pre-test probability of CAD by age, gender, and symptoms:</strong><br /><br /></p><table border=\"2\" width=\"100%\" cellspacing=\"2\"><tbody><tr><th valign=\"top\"><span class=\"web_bold\"> Age (yr)</span></th><th valign=\"top\"><span class=\"web_bold\"> Gender</span></th><th valign=\"top\"><span class=\"web_bold\"> Typical/Definite Angina Pectoris</span></th><th valign=\"top\"><span class=\"web_bold\"> Atypical/Probable Angina Pectoris </span></th><th valign=\"top\"><span class=\"web_bold\"> Non-Anginal Chest Pain</span></th><th valign=\"top\"><span class=\"web_bold\"> Asymptomatic</span></th></tr><tr><td>&le;39</td><td>Men</td><td>Intermediate</td><td>Intermediate</td><td>Low</td><td>Very Low</td></tr><tr><td>&nbsp;</td><td>Women</td><td>Intermediate</td><td>Very Low</td><td>Very Low</td><td>Very Low</td></tr><tr><td>40-49</td><td>Men</td><td>High</td><td>Intermediate</td><td>Intermediate</td><td>Low</td></tr><tr><td>&nbsp;</td><td>Women</td><td>Intermediate</td><td>Low</td><td>Very Low</td><td>Very Low</td></tr><tr><td>50-59</td><td>Men</td><td>High</td><td>Intermediate</td><td>Intermediate</td><td>Low</td></tr><tr><td>&nbsp;</td><td>Women</td><td>Intermediate</td><td>Intermediate</td><td>Low</td><td>Very Low</td></tr><tr><td>&ge;60</td><td>Men</td><td>High</td><td>Intermediate</td><td>Intermediate</td><td>Low</td></tr><tr><td>&nbsp;</td><td>Women</td><td>High</td><td>Intermediate</td><td>Intermediate</td><td>Low</td></tr></tbody></table><p><br /><br /><strong> High:</strong> Greater than 90% pre-test probability<br /><br /><strong> Intermediate:</strong> Between 10% and 90% pre-test probability<br /><br /><strong> Low:</strong> Between 5% and 10% pre-test probability<br /><br /><strong> Very Low:</strong> Less than 5% pre-test probability<br /><br />In summary, the choice of stress testing modality depends on many factors such as the patient's ability to exercise, the resting ECG, the clinical indication for performing the test, the patient's body habitus, and history of prior revascularization.<br /><br /><strong> The following are considered medically necessary for either the stress echo or SPECT MPI:</strong><br /><br />1. New, recurrent, or worsening cardiac symptoms <strong> AND</strong> any of the following:</p><ul><li>Physical inability to perform a maximum exercise workload<br /><br /></li><li>A history of CAD based on a prior anatomic evaluation of the coronary arteries OR a history of CABG or PCI<br /><br /></li><li>Syncope (i.e., no prodromal symptoms, not near syncope) in patient with high likelihood of CAD<br /><br /></li><li>Evidence or high suspicion of ventricular tachycardia<br /><br /></li><li>Age 50 years or greater and known diabetes mellitus<br /><br /></li><li>New or previously unrecognized uninterpretable ECG<br /><br /></li><li>Poorly controlled hypertension, generally, above 180 mm/Hg systolic, if the provider feels strongly that CAD needs evaluation prior to BP being controlled<br /><br /></li><li>ECG is uninterpretable for ischemia due to any one of the following:</li><ul><li>Complete Left Bundle Branch Block (right bundle branch does not render ECG uninterpretable for ischemia)</li><li>Ventricular paced rhythm</li><li>Pre-excitation pattern such as Wolff-Parkinson-White</li><li>&gt; 0.5 mm ST segment depression (NOT nonspecific ST/T wave changes)</li><li>LVH with repolarization abnormalities, also called LVH with strain (NOT without repolarization abnormalities or by voltage criteria)</li><li>T wave inversion in the inferior and/or lateral leads (leads II, AVF, V5, or V6)</li><li>Patient on digitalis preparation</li></ul><li>Worsening or continuing symptoms in a patient who had a normal or submaximal exercise stress test and there is suspicion of a false negative result</li><li>Patients with recent equivocal or borderline testing where ischemia remains a concern</li><li>Patients on beta blocker, calcium channel blocker, and/or antiarrhythmic medication when the documentation supports that an adequate workload may not be attainable to enable a fully diagnostic exercise study</li><li>History of false positive exercise stress test (e.g., one that is abnormal, but the abnormality does not appear to be due to macrovascular CAD)</li><li>High pretest probability of CAD (assuming emergency evaluation and/or prompt coronary angiography not previously implemented)</li></ul><p><br />2. Patients without clear cardiac symptoms in the presence of an elevated cardiac troponin<br /><br />3. Routine study &gt; 3 years after a PCI (stent) without cardiac symptoms and absent an evaluation for CAD within the past 2 years (stress echo, MPI SPECT, cardiac PET, coronary computed tomography angiography (CCTA), cardiac catheterization)<br /><br />4. Routine study &gt; 5 years after CABG without cardiac symptoms in a patient who has not had an evaluation for CAD within the past 2 years (stress echo, MPI SPECT, cardiac PET, coronary computed tomography angiography (CCTA), cardiac catheterization)<br /><br />5. Every 2 years in patients with documentation of previous &ldquo;silent ischemia&rdquo; (and diabetes mellitus) evident on previous MPI but not evident on previous exercise stress test<br /><br />6. To assess for CAD in a patient with unexplained or drug-induced intraventricular condition disturbances<br /><br />7. Prior anatomic imaging study (coronary angiogram or CCTA) to assess recently demonstrated coronary stenosis of uncertain functional significance in a major coronary branch can have one stress test with imaging<br /><br />8. Established CAD in a patient who had an acute coronary syndrome (ACS) (ST segment elevation MI (STEMI), Non&ndash;ST segment elevation MI (NSTEMI), unstable angina) event within the past 90 days provided that the patient has not undergone coronary angiography at the time of the acute event and is currently clinically stable<br /><br />9. Evaluating new, recurrent, or worsening left ventricular dysfunction/CHF<br /><br />10. Assessing myocardial viability in patients with significant ischemic ventricular dysfunction (suspected hibernating myocardium) and persistent symptoms or heart failure such that revascularization would be considered<br /><br />11. Pre-operative cardiac evaluation in patients undergoing non-cardiac surgery</p><ul style=\"list-style-type: circle;\"><li>Intermediate risk surgery (cardiac risk 1-5%) one or more cardiac risk factor(s) and inability to exercise adequately</li><li>high risk surgery (&gt; 5% cardiac risk)</li></ul><p><br />12. Asymptomatic patients with uninterpretable ECG and no evaluation for cardiac disease in the past 3 years<br /><br />13. Planned cardiac or other solid-organ transplant if no cardiac evaluation has been performed within the past year<br /><br />14. Patients to be treated with interleukin 2 (a pro-atherogenic agent) for various malignant disorders, etc.<br /><br />15. Patients with disease conditions associated with CAD (e.g., DM, AAA, PVD, carotid artery disease, CRF) and no documented evaluation was performed within the preceding 2 years<br /><br />16. Stress echocardiography will be considered reasonable and necessary for the evaluation of valvular heart disease and detection and management of occult pulmonary hypertension. <br /><br /><strong> The following are considered medically necessary for cardiac PET:</strong><br /><br /><em> 1. For the evaluation of coronary artery disease for perfusion of the heart via myocardial perfusion imaging, PET scans using either FDA-approved radiopharmaceutical Rubidium 82 (RB-82) or Ammonia N-13 when performed at rest or with pharmacological stress used for noninvasive imaging of the perfusion of the heart for the diagnosis and management of patients with known or suspected coronary artery disease, provided the following requirements are met:</em></p><p style=\"padding-left: 30px;\"><em>a.&nbsp; <em>The PET scan (whether at rest alone or rest with stress) is performed in place of, but not in addition to, a single photon emission computed tomography (SPECT)</em>in persons with conditions that may cause attenuation problems with SPECT, e.g., obesity (BMI greater than or equal to 35), large breasts, breast implants, left mastectomy, chest wall deformity, pleural or pericardial effusion;</em></p><p><strong>&nbsp;OR</strong></p><p style=\"padding-left: 30px;\">b. <em>The PET scan (whether at rest alone or rest with stress) is used following a SPECT that was found to be inconclusive. In these cases, the PET scan must have been considered necessary in order to determine what medical or surgical intervention is required to treat the patient. (For purposes of this requirement, an inconclusive test is a test(s) whose results are equivocal, technically uninterpretable, or discordant with a patient's other clinical data and must be documented in the beneficiary's file.)</em></p><p>For cardiac perfusion studies, patient selection criteria for PET scans involve an individual assessment of the pretest probability of CAD, based both on patient symptoms and risk factors:</p><ul style=\"list-style-type: disc;\"><li>Patients at low risk for CAD may be adequately evaluated with exercise electrocardiography.&nbsp;</li><li>Patients at high risk for CAD will typically not benefit from non-invasive assessment of myocardial perfusion since a negative test will not alter disease probability sufficiently to avoid invasive angiography.&nbsp;</li><li>Myocardial perfusion imaging is potentially beneficial for patients at intermediate risk of CAD (approximately 25% to 75% disease prevalence).</li></ul><p>The risk can be estimated using the patient's age, sex, and chest pain quality. The range for intermediate risk can vary.<br /><br />The following summarizes a characterization for patient populations at intermediate risk for CAD:<br /><br /><u> Typical Angina:</u><br /><br />Chest pain with all of the following characteristics:</p><ul><li>Substernal chest discomfort with characteristic quality and duration, and provoked by exertion or emotional stress, and relieved by rest or nitroglycerin</li><li>Men ages 30-39</li><li>Women ages 30-60</li></ul><p><u>Atypical Angina:</u></p><ul><li>Chest pain that lacks one of the characteristics of typical angina</li><li>Men ages 30-70</li><li>Women ages 50 years and older</li></ul><p><u>Non-anginal Chest Pain:</u></p><ul><li>Chest pain that meets one or none of the typical angina characteristics</li><li>Men ages 50 years and older</li><li>Women ages 60 years and older</li></ul><p><br />2. <em> For the determination of myocardial viability, using Fluorodeoxyglucose (F-18 FDG) as a radioactive tracer, when performed as a primary or initial diagnostic study prior to revascularization, or following an inconclusive SPECT. However, if a patient receives an FDG PET study with inconclusive results, a follow up SPECT test is not covered. The identification of patients with partial loss of heart muscle movement or hibernating myocardium is important in selecting candidates with compromised ventricular function to determine appropriateness for revascularization. Diagnostic tests such as FDG PET distinguish between dysfunctional but viable myocardial tissue and scar tissue in order to affect management decisions in patients with ischemic cardiomyopathy and left ventricular dysfunction.</em><br /><br />3. For the determination of cardiac involvement, using Fluorodeoxyglucose (F-18 FDG), to diagnose cardiac sarcoidosis in patients who are unable to undergo magnetic resonance imaging (MRI) scanning. Examples of patients who are unable to undergo MRI include, but are not limited to, patients with pacemakers, automatic implantable cardioverter defibrillators (AICDs), or other metal implants.<br /><br /><strong> <u> Limitations:</u></strong></p><ul><li>The CMS Manual System, Pub. 100-8, Program Integrity Manual, Chapter 13, Section 5.1, outlines that \"reasonable and necessary\" services are \"ordered and/or furnished by qualified personnel.\" Services will be considered medically reasonable and necessary only if performed by appropriately trained providers. A qualified physician for this service/procedure is defined as follows: A) Physician is properly enrolled in Medicare. B) Training and expertise must have been acquired within the framework of an accredited residency and/or fellowship program in the applicable specialty/subspecialty in the United States or must reflect equivalent education, training, and expertise endorsed by an academic institution in the United States and/or by the applicable specialty/subspecialty society in the United States.<br /><br /></li><li>The presence of risk factors for CAD, absent disease activity, is not a Medicare-covered indication for noninvasive testing. Screening for coronary artery disease in asymptomatic patients is not considered reasonable and necessary.<br /><br /></li><li>Patient selection should be based on clinical grounds. Pretest probability is based on age, gender, symptoms, and cardiac risk factors. Selection of the test should be made within the context of other testing modalities so that the expected information does not become redundant. In the instance where regional wall motion abnormalities and ejection fraction have been assessed, during the same episode of care, by other testing modalities (i.e. echocardiography), the medical necessity of repeating this assessment through the use of nuclear imaging modalities must be clearly documented in the medical record. The routine and repetitive monitoring of such patients beyond the first stress echo or MPI, in the absence of a documented clinical exacerbation (i.e., new symptoms or progression of existing symptoms) is not considered medically necessary.<br /><br /></li><li>MPI SPECT/PET and stress echo are not covered in patients with low pretest probability, interpretable ECG, and the ability to exercise.<br /><br /></li><li>MPI SPECT/PET and stress echo pre-operative evaluation for low risk non-cardiac surgery is not covered.<br /><br /></li><li>MPI SPECT/PET and stress echo are not covered for the pre-operative evaluation of planned intermediate risk, non-cardiac surgery, and the patient is able to exercise.<br /><br /></li><li>MPI SPECT/PET and stress echo are not covered for routine risk assessment for asymptomatic patients with known CAD, who have not had a revascularization procedure.<br /><br /></li><li>MPI SPECT/PET and stress echo are not covered for pre-operative, asymptomatic patients undergoing high risk non-cardiac surgery up to 1 year following normal stress echo, MPI SPECT, cardiac PET, coronary computed tomography angiography (CCTA), cardiac catheterization.<br /><br /></li><li>Exercise stress testing would not be expected to be performed with signs and symptoms of cardiopulmonary instability and generally-recognized contraindications (e.g., unstable angina, LV dysfunction).<br /><br /></li><li>For patients with an abnormal resting ECG because of left bundle branch block, pre-excitation syndrome, left ventricular hypertrophy (LVH) or digoxin therapy, an exercise or pharmacological imaging study should be considered because the accuracy of the exercise ECG in detecting provocable ischemia is reduced.<br /><br /></li><li>Cardiovascular stress testing may be performed in conjunction with additional cardiac diagnostic tests including echocardiography and nuclear cardiac imaging. It is expected that only the most appropriate test(s) necessary will be performed and billed to Medicare. The routine and repetitive monitoring of such patients beyond the first cardiac stress test, in the absence of a documented change in condition (i.e. new symptoms or progression of existing symptoms) is not considered medically necessary.<br /><br /></li><li>Exercise testing should be supervised by an appropriately trained physician. Exercise testing in selected patients can be performed safely by properly trained nurses, exercise physiologists, physician assistants, physical therapists, or medical technicians working directly under the supervision of a physician, who should be in the immediate vicinity and available for emergencies.<br /><br /></li><li>Given the limitations of uptake, low photon energy and distribution, the perfusion imaging codes are not generally covered on the same date of service.<br /><br /></li><li>Patients with initial abnormal test results have variable pre-test probabilities for adverse events, and the need and timing of follow up nuclear imaging studies must be justified in the medical record.<br /><br /></li><li>All cardiovascular nuclear tests must be referred by a physician or a qualified non-physician.<br /><br /></li><li>All cardiovascular nuclear tests must be performed under the general supervision of a physician. The Medicare Carriers Manual describes general supervision as applicable when a procedure is furnished under the physician&rsquo;s overall direction and control, but the physician&rsquo;s presence is not required during the performance of the procedure. Under general supervision guidelines, the training of the nonphysician personnel who actually perform the exercise procedure and the maintenance of the necessary equipment and supplies are the continuing responsibility of the supervising physician.<br /><br /></li><li>Neither exercise testing nor radiologic imaging is indicated in the initial months after PCI without specific symptoms (i.e., chest pain, ECG changes etc.).<br /><br /></li><li>Cardiovascular stress testing (with or without imaging) and cardiac imaging studies are not indicated if the results will not affect patient management decisions. If a decision to perform cardiac catheterization or other angiography has already been made, there is often no need for cardiovascular stress testing and/or cardiac imaging testing.<br /><br /></li><li><em> In the case of myocardial viability, the FDG positron emission tomography (PET) may be used following a SPECT that was found to be inconclusive. However, SPECT may not be used following an inconclusive FDG PET performed to evaluate myocardial viability.</em></li></ul>","diagnoses_support":null,"icd9_dont_support_para":null,"icd9_dont_support_ast":null,"diagnoses_dont_support":null,"coding_guidelines":null,"doc_reqs":null,"appendices":null,"util_guide":null,"source_info":"<p>Bateman TM, Heller GV, McGhie Iain, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT.<em> J Nucl Cardiol. </em>2006; 13:24-33.<br /><br />Brindis RG, Hendel RC, Peterson ED, et al. ACCF/ASNC Appropriateness Criteria for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT MPI). <em>J Am Coll Cardiol.</em> 2005: 46(8):1587-1605.<br /><br />Cigna Medical Coverage Policy: Cardiac Imaging Guidelines, Version 16.0, February 21, 2014.<br /><br />Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. <em>J Am Coll Cardiol.</em> 2012; 60(24):e44-e164.<br /><br />Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 Guideline Update for Exercise Testing A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Accessed at: https://my.americanheart.org/idc/groups/ahaecc-internal/@wcm/@sop/documents/downloadable/ucm_423807.pdf.<br /><br />Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults:<br />A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.<em> Circulation.</em> 2010; 122:e584&ndash;e636.<br /><br />Heart Disease and Stress Tests article accessed at www.webmd.com/heart-disease/guide/stress-test.<br /><br />Heller GV, Beanlands R, Merlino DA, et al. ASNC Model Coverage Policy: Cardiac positron emission tomographic imaging.<em> J Nucl Cardiol.</em> 2013; 20:916&ndash;47. <br /><br />Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging. <em>Circulation.</em> 2009; 119:e561-e587.<br /><br />McArdle BA, Dowsley TF, deKemp RA, et al. Does Rubidium-82 PET Have Superior Accuracy to SPECT Perfusion Imaging for the Diagnosis of Obstructive Coronary Disease? A Systematic Review and Meta-Analysis. <em>J Am Coll Cardiol. </em>2012; 60(18): 1828-1837.<br /><br />Peterson ED, Hendel RC, Stainback RF, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography. <em>Circulation.</em> 2008; 117:1478-1497.<br /><br />Rodgers GP, Ayanian JZ, Balady G, et al. American College of Cardiology/American Heart Association clinical competence statement on stress testing.<em> J Am Coll Cardiol.</em> 2000; 36(4):1441-1453.<br /><br />Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease.<em> J Am Coll Cardiol. </em>2014; 63(4):380-406.</p>","adv_meeting":null,"comment_start_dt":null,"comment_end_dt":null,"notice_start_dt":null,"rev_hist_num":null,"history_exp":null,"last_reviewed_on":"2017-03-30T00:00:00.000Z","thirty_percent":"N","status":"A","last_updated":"2017-09-22T17:27:27.000Z","draft_contact":null,"sticky_note":null,"revenue_para":"<p>Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.</p>","source_lcd_id":null,"add_icd10_info":null,"keywords":null,"associated_info":"<p><strong>Documentation Requirements </strong><br /><br />Medical record documentation maintained by the ordering/referring physician must indicate the medical necessity for performing the study, including:<br /><br />&bull; history and physical<br /><br />&bull; office/progress note, and<br /><br />&bull; test results<br /><br />If the provider of the service is other than the ordering/referring physician, the provider of the service must maintain hard copy documentation of test results and interpretation, along with copies of the ordering/referring physician&rsquo;s order for the studies. The physician must state the clinical indication/medical necessity for the study in the order for the test. All segments of the service must have a formal interpretation and report. <br /><br />When billing for the purchase of radiopharmaceutical(s), the dosage administered, unit price per dose, name and total charge of the radioactive drug must be on file. <br /><br />The rationale for selecting pharmacologic stress rather than exercise stress must be indicated in the medical record. <br /><br />The medical record must document when significant resting ECG abnormalities are present or a medication is being used and cannot be withdrawn that would interfere with the interpretation of a stress ECG, resulting in the selection of a myocardial perfusion study.<br /><br />Documentation that the required conditions (as indicated in the &ldquo;Indications and Limitations of Coverage and/or Medical Necessity&rdquo; section of this policy) for the PET scan performed has been met must be maintained by the referring physician in the beneficiary&rsquo;s medical record. PET scan facilities must keep patient record information on file for each Medicare patient for whom such a PET scan claim is made. The medical record must include standard information (e.g., age, sex, and height) along with any annotations regarding body size or type that indicates the need for a PET scan to determine the patient&rsquo;s condition. Documentation for PET scans for myocardial perfusion imaging or for myocardial viability that were performed following a SPECT should address the inconclusive nature of the SPECT by describing if the results were equivocal, technically uninterpretable, or discordant with the patient's other clinical data in the beneficiary's file. Documentation for the PET scan for the evaluation of coronary artery disease for myocardial perfusion that is performed in place of, but not in addition to, a SPECT must support that the beneficiary had a condition(s) that may cause attenuation problems with SPECT [e.g., obesity (BMI greater than or equal to 35), large breasts, breast implants, left mastectomy, chest wall deformity, pleural or pericardial effusion)]. Documentation containing medical necessity of procedures in addition to testing results such as images and reports must be maintained. Medical necessity for each service reported must be clearly demonstrated in the patient&rsquo;s medical record. When billing for the purchase of radiopharmaceutical(s), the dosage administered, unit price per dose, name and total charge of the radioactive drug must be documented in the file.<br /><br /><strong>Utilization Guidelines </strong><br /><br />It is expected that these services would be performed as indicated by current medical literature and/or standards of practice. When services are performed in excess of established parameters they may be subject to review for medical necessity.<br /><br />Reimbursement of cardiovascular stress testing (93015-93018) which exceeds the frequency or duration indicated by the accepted standards of medical practice are not covered unless there are special circumstances which justify additional cardiovascular stress testing. The routine and repetitive monitoring of such patients beyond the first cardiac stress test, in the absence of a documented change in condition (i.e. new symptoms or progression of existing symptoms) is not considered medically necessary.<br /><br />Frequency is considered excessive when services are performed more often than generally accepted by peers, and the reason for additional services is not justified in the documentation. Each patient&rsquo;s condition and response to treatment must medically warrant the number of services reported for payment. There must be medical necessity for each service reported to be clearly demonstrated in the patient&rsquo;s medical record. Repetitive frequent PET for myocardial perfusion imaging or myocardial viability at a frequency greater than one per year is not reasonable and necessary in the absence of a documented change in condition (i.e., new symptoms or progression of existing symptoms). It is expected that patients will not routinely require the maximum allowable number of services.</p>","notice_end_dt":null,"date_retired":null,"draft_released_date":null,"icd10_doc":"Y","synopsis_changes":null,"bibliography":"<p>N/A</p>","summary_of_evidence":"<p>N/A</p>","analysis_of_evidence":"<p>N/A</p>","orig_det_eff_dt_type":null,"rev_eff_dt_type":null},"hcpcCodes":[{"grp":1,"paragraph":null,"children":[{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93015","hcpc_code_version":62,"hcpc_code_group":1,"long_description":"CARDIOVASCULAR STRESS TEST USING MAXIMAL OR SUBMAXIMAL TREADMILL OR BICYCLE EXERCISE, CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING, AND/OR PHARMACOLOGICAL STRESS; WITH SUPERVISION, INTERPRETATION AND REPORT","short_description":"Cardiovascular stress test","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93016","hcpc_code_version":62,"hcpc_code_group":1,"long_description":"CARDIOVASCULAR STRESS TEST USING MAXIMAL OR SUBMAXIMAL TREADMILL OR BICYCLE EXERCISE, CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING, AND/OR PHARMACOLOGICAL STRESS; SUPERVISION ONLY, WITHOUT INTERPRETATION AND REPORT","short_description":"Cardiovascular stress test","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93017","hcpc_code_version":62,"hcpc_code_group":1,"long_description":"CARDIOVASCULAR STRESS TEST USING MAXIMAL OR SUBMAXIMAL TREADMILL OR BICYCLE EXERCISE, CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING, AND/OR PHARMACOLOGICAL STRESS; TRACING ONLY, WITHOUT INTERPRETATION AND REPORT","short_description":"Cardiovascular stress test","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93018","hcpc_code_version":62,"hcpc_code_group":1,"long_description":"CARDIOVASCULAR STRESS TEST USING MAXIMAL OR SUBMAXIMAL TREADMILL OR BICYCLE EXERCISE, CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING, AND/OR PHARMACOLOGICAL STRESS; INTERPRETATION AND REPORT ONLY","short_description":"Cardiovascular stress test","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null}]},{"grp":2,"paragraph":null,"children":[{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93350","hcpc_code_version":62,"hcpc_code_group":2,"long_description":"ECHOCARDIOGRAPHY, TRANSTHORACIC, REAL-TIME WITH IMAGE DOCUMENTATION (2D), INCLUDES M-MODE RECORDING, WHEN PERFORMED, DURING REST AND CARDIOVASCULAR STRESS TEST USING TREADMILL, BICYCLE EXERCISE AND/OR PHARMACOLOGICALLY INDUCED STRESS, WITH INTERPRETATION AND REPORT;","short_description":"Stress tte only","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93351","hcpc_code_version":62,"hcpc_code_group":2,"long_description":"ECHOCARDIOGRAPHY, TRANSTHORACIC, REAL-TIME WITH IMAGE DOCUMENTATION (2D), INCLUDES M-MODE RECORDING, WHEN PERFORMED, DURING REST AND CARDIOVASCULAR STRESS TEST USING TREADMILL, BICYCLE EXERCISE AND/OR PHARMACOLOGICALLY INDUCED STRESS, WITH INTERPRETATION AND REPORT; INCLUDING PERFORMANCE OF CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING, WITH SUPERVISION BY A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL","short_description":"Stress tte complete","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"93352","hcpc_code_version":62,"hcpc_code_group":2,"long_description":"USE OF ECHOCARDIOGRAPHIC CONTRAST AGENT DURING STRESS ECHOCARDIOGRAPHY (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE)","short_description":"Admin ecg contrast agent","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null}]},{"grp":3,"paragraph":null,"children":[{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78451","hcpc_code_version":62,"hcpc_code_group":3,"long_description":"MYOCARDIAL PERFUSION IMAGING, TOMOGRAPHIC (SPECT) (INCLUDING ATTENUATION CORRECTION, QUALITATIVE OR QUANTITATIVE WALL MOTION, EJECTION FRACTION BY FIRST PASS OR GATED TECHNIQUE, ADDITIONAL QUANTIFICATION, WHEN PERFORMED); SINGLE STUDY, AT REST OR STRESS (EXERCISE OR PHARMACOLOGIC)","short_description":"Ht muscle image spect sing","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78452","hcpc_code_version":62,"hcpc_code_group":3,"long_description":"MYOCARDIAL PERFUSION IMAGING, TOMOGRAPHIC (SPECT) (INCLUDING ATTENUATION CORRECTION, QUALITATIVE OR QUANTITATIVE WALL MOTION, EJECTION FRACTION BY FIRST PASS OR GATED TECHNIQUE, ADDITIONAL QUANTIFICATION, WHEN PERFORMED); MULTIPLE STUDIES, AT REST AND/OR STRESS (EXERCISE OR PHARMACOLOGIC) AND/OR REDISTRIBUTION AND/OR REST REINJECTION","short_description":"Ht muscle image spect mult","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78453","hcpc_code_version":62,"hcpc_code_group":3,"long_description":"MYOCARDIAL PERFUSION IMAGING, PLANAR (INCLUDING QUALITATIVE OR QUANTITATIVE WALL MOTION, EJECTION FRACTION BY FIRST PASS OR GATED TECHNIQUE, ADDITIONAL QUANTIFICATION, WHEN PERFORMED); SINGLE STUDY, AT REST OR STRESS (EXERCISE OR PHARMACOLOGIC)","short_description":"Ht muscle image planar sing","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78454","hcpc_code_version":62,"hcpc_code_group":3,"long_description":"MYOCARDIAL PERFUSION IMAGING, PLANAR (INCLUDING QUALITATIVE OR QUANTITATIVE WALL MOTION, EJECTION FRACTION BY FIRST PASS OR GATED TECHNIQUE, ADDITIONAL QUANTIFICATION, WHEN PERFORMED); MULTIPLE STUDIES, AT REST AND/OR STRESS (EXERCISE OR PHARMACOLOGIC) AND/OR REDISTRIBUTION AND/OR REST REINJECTION","short_description":"Ht musc image planar mult","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null}]},{"grp":4,"paragraph":null,"children":[{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78459","hcpc_code_version":62,"hcpc_code_group":4,"long_description":"MYOCARDIAL IMAGING, POSITRON EMISSION TOMOGRAPHY (PET), METABOLIC EVALUATION","short_description":"Heart muscle imaging (pet)","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78491","hcpc_code_version":62,"hcpc_code_group":4,"long_description":"MYOCARDIAL IMAGING, POSITRON EMISSION TOMOGRAPHY (PET), PERFUSION; SINGLE STUDY AT REST OR STRESS","short_description":"Heart image (pet) single","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"78492","hcpc_code_version":62,"hcpc_code_group":4,"long_description":"MYOCARDIAL IMAGING, POSITRON EMISSION TOMOGRAPHY (PET), PERFUSION; MULTIPLE STUDIES AT REST AND/OR STRESS","short_description":"Heart image (pet) multiple","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"A9526","hcpc_code_version":62,"hcpc_code_group":4,"long_description":"NITROGEN N-13 AMMONIA, DIAGNOSTIC, PER STUDY DOSE, UP TO 40 MILLICURIES","short_description":"Nitrogen n-13 ammonia","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"A9552","hcpc_code_version":62,"hcpc_code_group":4,"long_description":"FLUORODEOXYGLUCOSE F-18 FDG, DIAGNOSTIC, PER STUDY DOSE, UP TO 45 MILLICURIES","short_description":"F18 fdg","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null},{"lcd_id":36209,"lcd_version":15,"hcpc_code_id":"A9555","hcpc_code_version":62,"hcpc_code_group":4,"long_description":"RUBIDIUM RB-82, DIAGNOSTIC, PER STUDY DOSE, UP TO 60 MILLICURIES","short_description":"Rb82 rubidium","last_updated":"2017-09-22T17:27:27.000Z","range":"N","paragraph":null}]}],"contractors":[{"lcd_id":36209,"lcd_version":15,"contractor_id":368,"contractor_type_id":12,"contractor_version":1,"last_updated":"2014-07-16T08:45:08.000Z","contractor_bus_name":"First Coast Service Options, Inc.","contractor_number":"09101","dmerc_rgn":10,"address1":"532 Riverside Avenue ","address2":null,"address3":null,"city":"Jacksonville","state_id":12,"zipcode":"32202","phone":"8776028816","fax":null,"status":"A","url":"http://medicare.fcso.com","email":null,"ignore":null,"status_flag":"Y","cmd_name":"James J. Corcoran, MD, MPH","cmd_title":"Chief Contractor Medical Director ","contractor_subtype_id":1,"description":"A and B MAC","subtype_description":"MAC A","states":"Florida","super_mac_description":"J - N"},{"lcd_id":36209,"lcd_version":15,"contractor_id":369,"contractor_type_id":12,"contractor_version":1,"last_updated":"2014-07-16T08:38:25.000Z","contractor_bus_name":"First Coast Service Options, Inc.","contractor_number":"09201","dmerc_rgn":10,"address1":"532 Riverside Avenue","address2":null,"address3":null,"city":"Jacksonville","state_id":12,"zipcode":"32202","phone":"8886644112","fax":null,"status":"A","url":"http://medicare.fcso.com","email":null,"ignore":null,"status_flag":"Y","cmd_name":"James J. Corcoran, MD, MPH","cmd_title":"Chief Contractor Medical Director","contractor_subtype_id":1,"description":"A and B MAC","subtype_description":"MAC A","states":"Puerto Rico, Virgin Islands","super_mac_description":"J - N"},{"lcd_id":36209,"lcd_version":15,"contractor_id":370,"contractor_type_id":12,"contractor_version":1,"last_updated":"2014-07-16T08:37:37.000Z","contractor_bus_name":"First Coast Service Options, Inc.","contractor_number":"09102","dmerc_rgn":10,"address1":"532 Riverside Avenue","address2":null,"address3":null,"city":"Jacksonville","state_id":12,"zipcode":"32202","phone":"8664549007","fax":null,"status":"A","url":"http://medicare.fcso.com","email":null,"ignore":null,"status_flag":"Y","cmd_name":"James J. Corcoran, MD, MPH","cmd_title":"Chief Contractor Medical Director","contractor_subtype_id":2,"description":"A and B MAC","subtype_description":"MAC B","states":"Florida","super_mac_description":"J - N"},{"lcd_id":36209,"lcd_version":15,"contractor_id":371,"contractor_type_id":12,"contractor_version":1,"last_updated":"2014-07-16T08:39:06.000Z","contractor_bus_name":"First Coast Service Options, Inc.","contractor_number":"09202","dmerc_rgn":10,"address1":"532 Riverside Avenue","address2":null,"address3":null,"city":"Jacksonville","state_id":12,"zipcode":"32202","phone":"8664549007","fax":null,"status":"A","url":"http://medicare.fcso.com","email":null,"ignore":null,"status_flag":"Y","cmd_name":"James J. Corcoran, MD, MPH","cmd_title":"Chief Contractor Medical Director","contractor_subtype_id":2,"description":"A and B MAC","subtype_description":"MAC B","states":"Puerto Rico","super_mac_description":"J - N"},{"lcd_id":36209,"lcd_version":15,"contractor_id":372,"contractor_type_id":12,"contractor_version":1,"last_updated":"2014-07-16T08:40:19.000Z","contractor_bus_name":"First Coast Service Options, Inc.","contractor_number":"09302","dmerc_rgn":10,"address1":"532 Riverside Avenue","address2":null,"address3":null,"city":"Jacksonville","state_id":12,"zipcode":"32202","phone":"8664549007","fax":null,"status":"A","url":"http://medicare.fcso.com","email":null,"ignore":null,"status_flag":"Y","cmd_name":"James J. Corcoran, MD, MPH","cmd_title":"Chief Contractor Medical Director","contractor_subtype_id":2,"description":"A and B MAC","subtype_description":"MAC B","states":"Virgin Islands","super_mac_description":"J - N"}],"billCodes":[{"lcd_id":36209,"lcd_version":15,"bill_code_id":12,"bill_code_version":6,"description":"Hospital Inpatient (Medicare Part B only)","last_updated":"2017-09-22T17:27:27.000Z"},{"lcd_id":36209,"lcd_version":15,"bill_code_id":13,"bill_code_version":6,"description":"Hospital Outpatient","last_updated":"2017-09-22T17:27:27.000Z"},{"lcd_id":36209,"lcd_version":15,"bill_code_id":14,"bill_code_version":6,"description":"Hospital - Laboratory Services Provided to Non-patients","last_updated":"2017-09-22T17:27:27.000Z"},{"lcd_id":36209,"lcd_version":15,"bill_code_id":22,"bill_code_version":6,"description":"Skilled Nursing - Inpatient (Medicare Part B only)","last_updated":"2017-09-22T17:27:27.000Z"},{"lcd_id":36209,"lcd_version":15,"bill_code_id":23,"bill_code_version":6,"description":"Skilled Nursing - Outpatient","last_updated":"2017-09-22T17:27:27.000Z"},{"lcd_id":36209,"lcd_version":15,"bill_code_id":71,"bill_code_version":6,"description":"Clinic - Rural Health","last_updated":"2017-09-22T17:27:27.000Z"},{"lcd_id":36209,"lcd_version":15,"bill_code_id":85,"bill_code_version":6,"description":"Critical Access Hospital","last_updated":"2017-09-22T17:27:27.000Z"}],"revenueCodes":[{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0340","revenue_code_version":9,"description":"Nuclear Medicine - General Classification","last_updated":"2017-09-22T17:27:27.000Z","range":"X"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0341","revenue_code_version":9,"description":"Nuclear Medicine - Diagnostic","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0342","revenue_code_version":9,"description":"Nuclear Medicine - Therapeutic","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0343","revenue_code_version":9,"description":"Nuclear Medicine - Diagnostic Radiopharmaceuticals","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0344","revenue_code_version":9,"description":"Nuclear Medicine - Therapeutic Radiopharmaceuticals","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0349","revenue_code_version":9,"description":"Nuclear Medicine - Other Nuclear Medicine","last_updated":"2017-09-22T17:27:27.000Z","range":"Z"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0404","revenue_code_version":9,"description":"Other Imaging Services - Positron Emission Tomography","last_updated":"2017-09-22T17:27:27.000Z","range":"N"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0480","revenue_code_version":9,"description":"Cardiology - General Classification","last_updated":"2017-09-22T17:27:27.000Z","range":"X"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0481","revenue_code_version":9,"description":"Cardiology - Cardiac Cath Lab","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0482","revenue_code_version":9,"description":"Cardiology - Stress Test","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0483","revenue_code_version":9,"description":"Cardiology - Echocardiology","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0489","revenue_code_version":9,"description":"Cardiology - Other Cardiology","last_updated":"2017-09-22T17:27:27.000Z","range":"Z"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0920","revenue_code_version":9,"description":"Other Diagnostic Services - General Classification","last_updated":"2017-09-22T17:27:27.000Z","range":"X"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0921","revenue_code_version":9,"description":"Other Diagnostic Services - Peripheral Vascular Lab","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0922","revenue_code_version":9,"description":"Other Diagnostic Services - Electromyelgram","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0923","revenue_code_version":9,"description":"Other Diagnostic Services - Pap Smear","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0924","revenue_code_version":9,"description":"Other Diagnostic Services - Allergy Test","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0925","revenue_code_version":9,"description":"Other Diagnostic Services - Pregnancy Test","last_updated":"2017-09-22T17:27:27.000Z","range":"Y"},{"lcd_id":36209,"lcd_version":15,"revenue_code_id":"0929","revenue_code_version":9,"description":"Other Diagnostic Services - Other Diagnostic Service","last_updated":"2017-09-22T17:27:27.000Z","range":"Z"}],"icdCodes":[{"grp":1,"paragraph":null,"description":"Acute rheumatic pericarditis","children":[{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I01.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10798,"description":"Acute rheumatic pericarditis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I01.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10799,"description":"Acute rheumatic endocarditis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I01.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10800,"description":"Acute rheumatic myocarditis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I01.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10801,"description":"Other acute rheumatic heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I01.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10802,"description":"Acute rheumatic heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I02.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":10804,"description":"Rheumatic chorea with heart involvement","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10807,"description":"Rheumatic mitral stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10808,"description":"Rheumatic mitral insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10809,"description":"Rheumatic mitral stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10810,"description":"Other rheumatic mitral valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10811,"description":"Rheumatic mitral valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10813,"description":"Rheumatic aortic stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10814,"description":"Rheumatic aortic insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10815,"description":"Rheumatic aortic stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10816,"description":"Other rheumatic aortic valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10817,"description":"Rheumatic aortic valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":10825,"description":"Rheumatic disorders of both mitral and aortic valves","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10829,"description":"Other rheumatic multiple valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10830,"description":"Rheumatic multiple valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I11.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10841,"description":"Hypertensive heart disease with heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I11.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10842,"description":"Hypertensive heart disease without heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I13.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10847,"description":"Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I13.10","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10849,"description":"Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I13.11","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10850,"description":"Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I13.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10851,"description":"Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10863,"description":"Unstable angina","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10864,"description":"Angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10865,"description":"Other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10866,"description":"Angina pectoris, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.01","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10869,"description":"ST elevation (STEMI) myocardial infarction involving left main coronary artery","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.02","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10870,"description":"ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.09","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10871,"description":"ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.11","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10873,"description":"ST elevation (STEMI) myocardial infarction involving right coronary artery","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.19","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10874,"description":"ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.21","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10876,"description":"ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.29","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10877,"description":"ST elevation (STEMI) myocardial infarction involving other sites","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.3","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10878,"description":"ST elevation (STEMI) myocardial infarction of unspecified site","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.4","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10879,"description":"Non-ST elevation (NSTEMI) myocardial infarction","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10880,"description":"Acute myocardial infarction, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.A1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10882,"description":"Myocardial infarction type 2","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I21.A9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10883,"description":"Other myocardial infarction type","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I22.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10885,"description":"Subsequent ST elevation (STEMI) myocardial infarction of anterior wall","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I22.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10886,"description":"Subsequent ST elevation (STEMI) myocardial infarction of inferior wall","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I22.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10887,"description":"Subsequent non-ST elevation (NSTEMI) myocardial infarction","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I22.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10888,"description":"Subsequent ST elevation (STEMI) myocardial infarction of other sites","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I22.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10889,"description":"Subsequent ST elevation (STEMI) myocardial infarction of unspecified site","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10901,"description":"Acute coronary thrombosis not resulting in myocardial infarction","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10902,"description":"Dressler's syndrome","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10903,"description":"Other forms of acute ischemic heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10904,"description":"Acute ischemic heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.10","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10907,"description":"Atherosclerotic heart disease of native coronary artery without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.110","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10909,"description":"Atherosclerotic heart disease of native coronary artery with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.111","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10910,"description":"Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.118","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10911,"description":"Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.119","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10912,"description":"Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10913,"description":"Old myocardial infarction","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.3","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10914,"description":"Aneurysm of heart","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.41","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10916,"description":"Coronary artery aneurysm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.42","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10917,"description":"Coronary artery dissection","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.5","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10918,"description":"Ischemic cardiomyopathy","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.6","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10919,"description":"Silent myocardial ischemia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.700","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10922,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.701","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10923,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.708","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10924,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.709","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10925,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.710","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10927,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.711","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10928,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.718","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10929,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.719","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10930,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.720","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10932,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.721","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10933,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.728","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10934,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.729","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10935,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.730","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10937,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.731","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10938,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.738","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10939,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.739","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10940,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.750","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10942,"description":"Atherosclerosis of native coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.751","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10943,"description":"Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.758","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10944,"description":"Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.759","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10945,"description":"Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.760","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10947,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.761","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10948,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.768","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10949,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.769","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10950,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.790","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10952,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.791","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10953,"description":"Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.798","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10954,"description":"Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.799","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10955,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.810","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10958,"description":"Atherosclerosis of coronary artery bypass graft(s) without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.811","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10959,"description":"Atherosclerosis of native coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.812","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10960,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.82","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10961,"description":"Chronic total occlusion of coronary artery","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.83","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10962,"description":"Coronary atherosclerosis due to lipid rich plaque","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.84","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10963,"description":"Coronary atherosclerosis due to calcified coronary lesion","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.89","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10964,"description":"Other forms of chronic ischemic heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10965,"description":"Chronic ischemic heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I26.01","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10968,"description":"Septic pulmonary embolism with acute cor pulmonale","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I26.02","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10969,"description":"Saddle embolus of pulmonary artery with acute cor pulmonale","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I26.09","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10970,"description":"Other pulmonary embolism with acute cor pulmonale","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I26.90","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10972,"description":"Septic pulmonary embolism without acute cor pulmonale","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I26.92","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10973,"description":"Saddle embolus of pulmonary artery without acute cor pulmonale","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I26.99","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10974,"description":"Other pulmonary embolism without acute cor pulmonale","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":10976,"description":"Primary pulmonary hypertension","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10977,"description":"Kyphoscoliotic heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.20","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10979,"description":"Pulmonary hypertension, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.21","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10980,"description":"Secondary pulmonary arterial hypertension","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.22","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10981,"description":"Pulmonary hypertension due to left heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.23","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10982,"description":"Pulmonary hypertension due to lung diseases and hypoxia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.24","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10983,"description":"Chronic thromboembolic pulmonary hypertension","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.29","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10984,"description":"Other secondary pulmonary hypertension","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.81","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10986,"description":"Cor pulmonale (chronic)","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.82","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10987,"description":"Chronic pulmonary embolism","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.83","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10988,"description":"Eisenmenger's syndrome","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.89","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":10989,"description":"Other specified pulmonary heart diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I27.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":10990,"description":"Pulmonary heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11014,"description":"Nonrheumatic mitral (valve) insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11015,"description":"Nonrheumatic mitral (valve) prolapse","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11016,"description":"Nonrheumatic mitral (valve) stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11017,"description":"Other nonrheumatic mitral valve disorders","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11018,"description":"Nonrheumatic mitral valve disorder, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11020,"description":"Nonrheumatic aortic (valve) stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11021,"description":"Nonrheumatic aortic (valve) insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11022,"description":"Nonrheumatic aortic (valve) stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11023,"description":"Other nonrheumatic aortic valve disorders","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11024,"description":"Nonrheumatic aortic valve disorder, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I46.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11085,"description":"Cardiac arrest due to underlying cardiac condition","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I46.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11086,"description":"Cardiac arrest due to other underlying condition","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I46.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11087,"description":"Cardiac arrest, cause unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I47.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11089,"description":"Re-entry ventricular arrhythmia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I47.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11090,"description":"Supraventricular tachycardia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I47.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11091,"description":"Ventricular tachycardia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I47.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11092,"description":"Paroxysmal tachycardia, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11094,"description":"Paroxysmal atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11095,"description":"Persistent atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11096,"description":"Chronic atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.3","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11097,"description":"Typical atrial flutter","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.4","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11098,"description":"Atypical atrial flutter","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.91","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11100,"description":"Unspecified atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.92","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11101,"description":"Unspecified atrial flutter","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.01","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11104,"description":"Ventricular fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.02","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11105,"description":"Ventricular flutter","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11106,"description":"Atrial premature depolarization","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11107,"description":"Junctional premature depolarization","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.3","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11108,"description":"Ventricular premature depolarization","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.40","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11110,"description":"Unspecified premature depolarization","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.49","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11111,"description":"Other premature depolarization","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.5","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11112,"description":"Sick sinus syndrome","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11113,"description":"Other specified cardiac arrhythmias","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I49.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11114,"description":"Cardiac arrhythmia, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":11116,"description":"Left ventricular failure, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.20","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11118,"description":"Unspecified systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.21","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11119,"description":"Acute systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.22","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11120,"description":"Chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.23","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11121,"description":"Acute on chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.30","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11123,"description":"Unspecified diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.31","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11124,"description":"Acute diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.32","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11125,"description":"Chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.33","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11126,"description":"Acute on chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.40","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11128,"description":"Unspecified combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.41","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11129,"description":"Acute combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.42","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11130,"description":"Chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.43","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11131,"description":"Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.810","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11134,"description":"Right heart failure, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.811","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11135,"description":"Acute right heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.812","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11136,"description":"Chronic right heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.813","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11137,"description":"Acute on chronic right heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.814","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11138,"description":"Right heart failure due to left heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.82","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11139,"description":"Biventricular heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.83","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11140,"description":"High output heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.84","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11141,"description":"End stage heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.89","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":11142,"description":"Other heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":11143,"description":"Heart failure, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R00.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":28531,"description":"Tachycardia, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R00.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28532,"description":"Bradycardia, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R00.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28533,"description":"Palpitations","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R00.8","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28534,"description":"Other abnormalities of heart beat","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R00.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":28535,"description":"Unspecified abnormalities of heart beat","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R01.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":28537,"description":"Benign and innocent cardiac murmurs","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R01.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28538,"description":"Cardiac murmur, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R01.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":28539,"description":"Other cardiac sounds","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.00","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":28554,"description":"Dyspnea, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.01","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28555,"description":"Orthopnea","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.02","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28556,"description":"Shortness of breath","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.03","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28557,"description":"Acute respiratory distress","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.09","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":28558,"description":"Other forms of dyspnea","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":28560,"description":"Wheezing","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.3","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28561,"description":"Periodic breathing","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.4","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":28562,"description":"Hyperventilation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.81","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":28567,"description":"Apnea, not elsewhere classified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.82","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28568,"description":"Tachypnea, not elsewhere classified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.83","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28569,"description":"Snoring","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.89","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28570,"description":"Other abnormalities of breathing","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R06.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":28571,"description":"Unspecified abnormalities of breathing","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"B","sort_order":28574,"description":"Chest pain on breathing","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.2","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28575,"description":"Precordial pain","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.81","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28577,"description":"Pleurodynia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.82","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28578,"description":"Intercostal pain","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.89","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"M","sort_order":28579,"description":"Other chest pain","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.9","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"E","sort_order":28580,"description":"Chest pain, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R42","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":29002,"description":"Dizziness and giddiness","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R55","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":29092,"description":"Syncope and collapse","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R94.31","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":29396,"description":"Abnormal electrocardiogram [ECG] [EKG]","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z09","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":92622,"description":"Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z48.21","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":93143,"description":"Encounter for aftercare following heart transplant","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z48.280","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":93148,"description":"Encounter for aftercare following heart-lung transplant","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z94.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":93990,"description":"Heart transplant status","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z94.3","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":93992,"description":"Heart and lungs transplant status","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z95.0","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":94005,"description":"Presence of cardiac pacemaker","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z95.1","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":94006,"description":"Presence of aortocoronary bypass graft","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z95.5","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":94010,"description":"Presence of coronary angioplasty implant and graft","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z98.61","icd10_code_version":5,"icd10_support_group":1,"asterisk":"N","range":"N","sort_order":94100,"description":"Coronary angioplasty status","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null}]},{"grp":2,"paragraph":null,"description":"Rheumatic mitral stenosis","children":[{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10807,"description":"Rheumatic mitral stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10808,"description":"Rheumatic mitral insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10809,"description":"Rheumatic mitral stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10810,"description":"Other rheumatic mitral valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I05.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10811,"description":"Rheumatic mitral valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10813,"description":"Rheumatic aortic stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10814,"description":"Rheumatic aortic insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10815,"description":"Rheumatic aortic stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10816,"description":"Other rheumatic aortic valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I06.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10817,"description":"Rheumatic aortic valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I07.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10819,"description":"Rheumatic tricuspid stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I07.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10820,"description":"Rheumatic tricuspid insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I07.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10821,"description":"Rheumatic tricuspid stenosis and insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I07.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10822,"description":"Other rheumatic tricuspid valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I07.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10823,"description":"Rheumatic tricuspid valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10825,"description":"Rheumatic disorders of both mitral and aortic valves","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10826,"description":"Rheumatic disorders of both mitral and tricuspid valves","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10827,"description":"Rheumatic disorders of both aortic and tricuspid valves","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.3","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10828,"description":"Combined rheumatic disorders of mitral, aortic and tricuspid valves","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10829,"description":"Other rheumatic multiple valve diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I08.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10830,"description":"Rheumatic multiple valve disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I09.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10833,"description":"Rheumatic diseases of endocardium, valve unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I09.81","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10836,"description":"Rheumatic heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I09.89","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10837,"description":"Other specified rheumatic heart diseases","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I09.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10838,"description":"Rheumatic heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10863,"description":"Unstable angina","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10864,"description":"Angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10865,"description":"Other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10866,"description":"Angina pectoris, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10901,"description":"Acute coronary thrombosis not resulting in myocardial infarction","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10903,"description":"Other forms of acute ischemic heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10904,"description":"Acute ischemic heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.10","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10907,"description":"Atherosclerotic heart disease of native coronary artery without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.110","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10909,"description":"Atherosclerotic heart disease of native coronary artery with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.111","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10910,"description":"Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.118","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10911,"description":"Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.119","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10912,"description":"Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10913,"description":"Old myocardial infarction","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.3","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10914,"description":"Aneurysm of heart","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.41","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10916,"description":"Coronary artery aneurysm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.42","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10917,"description":"Coronary artery dissection","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.5","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10918,"description":"Ischemic cardiomyopathy","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.6","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10919,"description":"Silent myocardial ischemia","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.700","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10922,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.701","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10923,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.708","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10924,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.709","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10925,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.710","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10927,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.711","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10928,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.718","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10929,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.719","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10930,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.720","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10932,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.721","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10933,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.728","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10934,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.729","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10935,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.730","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10937,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.731","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10938,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.738","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10939,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.739","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10940,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.750","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10942,"description":"Atherosclerosis of native coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.751","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10943,"description":"Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.758","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10944,"description":"Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.759","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10945,"description":"Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.760","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10947,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.761","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10948,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.768","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10949,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.769","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10950,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.790","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10952,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.791","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10953,"description":"Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.798","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":10954,"description":"Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.799","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10955,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.811","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":10959,"description":"Atherosclerosis of native coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.812","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":10960,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.84","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10963,"description":"Coronary atherosclerosis due to calcified coronary lesion","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.89","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10964,"description":"Other forms of chronic ischemic heart disease","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":10965,"description":"Chronic ischemic heart disease, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11014,"description":"Nonrheumatic mitral (valve) insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11015,"description":"Nonrheumatic mitral (valve) prolapse","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11016,"description":"Nonrheumatic mitral (valve) stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11017,"description":"Other nonrheumatic mitral valve disorders","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11018,"description":"Nonrheumatic mitral valve disorder, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11020,"description":"Nonrheumatic aortic (valve) stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11021,"description":"Nonrheumatic aortic (valve) insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11022,"description":"Nonrheumatic aortic (valve) stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11023,"description":"Other nonrheumatic aortic valve disorders","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I35.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11024,"description":"Nonrheumatic aortic valve disorder, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I36.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11026,"description":"Nonrheumatic tricuspid (valve) stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I36.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11027,"description":"Nonrheumatic tricuspid (valve) insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I36.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11028,"description":"Nonrheumatic tricuspid (valve) stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I36.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11029,"description":"Other nonrheumatic tricuspid valve disorders","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I36.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11030,"description":"Nonrheumatic tricuspid valve disorder, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I37.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11032,"description":"Nonrheumatic pulmonary valve stenosis","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I37.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11033,"description":"Nonrheumatic pulmonary valve insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I37.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11034,"description":"Nonrheumatic pulmonary valve stenosis with insufficiency","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I37.8","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11035,"description":"Other nonrheumatic pulmonary valve disorders","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I37.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11036,"description":"Nonrheumatic pulmonary valve disorder, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.30","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11062,"description":"Unspecified atrioventricular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.39","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11063,"description":"Other atrioventricular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.4","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11064,"description":"Left anterior fascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.5","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11065,"description":"Left posterior fascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.60","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11067,"description":"Unspecified fascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.69","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11068,"description":"Other fascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.7","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11069,"description":"Left bundle-branch block, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11071,"description":"Right fascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.10","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11073,"description":"Unspecified right bundle-branch block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.19","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11074,"description":"Other right bundle-branch block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11075,"description":"Bifascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.3","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11076,"description":"Trifascicular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.4","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11077,"description":"Nonspecific intraventricular block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.5","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11078,"description":"Other specified heart block","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.6","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11079,"description":"Pre-excitation syndrome","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.0","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":11094,"description":"Paroxysmal atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.2","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":11096,"description":"Chronic atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.91","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":11100,"description":"Unspecified atrial fibrillation","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.1","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11116,"description":"Left ventricular failure, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.20","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11118,"description":"Unspecified systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.21","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11119,"description":"Acute systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.22","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11120,"description":"Chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.23","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11121,"description":"Acute on chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.30","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11123,"description":"Unspecified diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.31","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11124,"description":"Acute diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.32","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11125,"description":"Chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.33","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11126,"description":"Acute on chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.40","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11128,"description":"Unspecified combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.41","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11129,"description":"Acute combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.42","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11130,"description":"Chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.43","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11131,"description":"Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.810","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11134,"description":"Right heart failure, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.811","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11135,"description":"Acute right heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.812","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11136,"description":"Chronic right heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.813","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11137,"description":"Acute on chronic right heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.814","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11138,"description":"Right heart failure due to left heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.82","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11139,"description":"Biventricular heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.83","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11140,"description":"High output heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.84","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11141,"description":"End stage heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.89","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11142,"description":"Other heart failure","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.9","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11143,"description":"Heart failure, unspecified","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.211","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":11668,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, right leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.212","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11669,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, left leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.213","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11670,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.218","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11671,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.219","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11672,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.221","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11674,"description":"Atherosclerosis of native arteries of extremities with rest pain, right leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.222","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11675,"description":"Atherosclerosis of native arteries of extremities with rest pain, left leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.223","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11676,"description":"Atherosclerosis of native arteries of extremities with rest pain, bilateral legs","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.228","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11677,"description":"Atherosclerosis of native arteries of extremities with rest pain, other extremity","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.229","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11678,"description":"Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.231","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11680,"description":"Atherosclerosis of native arteries of right leg with ulceration of thigh","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.232","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11681,"description":"Atherosclerosis of native arteries of right leg with ulceration of calf","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.233","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11682,"description":"Atherosclerosis of native arteries of right leg with ulceration of ankle","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.234","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11683,"description":"Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.235","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11684,"description":"Atherosclerosis of native arteries of right leg with ulceration of other part of foot","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.238","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11685,"description":"Atherosclerosis of native arteries of right leg with ulceration of other part of lower right leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.239","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11686,"description":"Atherosclerosis of native arteries of right leg with ulceration of unspecified site","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.241","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11688,"description":"Atherosclerosis of native arteries of left leg with ulceration of thigh","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.242","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11689,"description":"Atherosclerosis of native arteries of left leg with ulceration of calf","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.243","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11690,"description":"Atherosclerosis of native arteries of left leg with ulceration of ankle","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.244","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11691,"description":"Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.245","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11692,"description":"Atherosclerosis of native arteries of left leg with ulceration of other part of foot","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.248","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11693,"description":"Atherosclerosis of native arteries of left leg with ulceration of other part of lower left leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.249","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11694,"description":"Atherosclerosis of native arteries of left leg with ulceration of unspecified site","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.25","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11695,"description":"Atherosclerosis of native arteries of other extremities with ulceration","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.261","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11697,"description":"Atherosclerosis of native arteries of extremities with gangrene, right leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.262","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11698,"description":"Atherosclerosis of native arteries of extremities with gangrene, left leg","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.263","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11699,"description":"Atherosclerosis of native arteries of extremities with gangrene, bilateral legs","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.268","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":11700,"description":"Atherosclerosis of native arteries of extremities with gangrene, other extremity","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.269","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":11701,"description":"Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity","last_updated":"2017-09-22T17:27:27.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R94.31","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":29396,"description":"Abnormal electrocardiogram [ECG] [EKG]","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.0X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73609,"description":"Adverse effect of glucocorticoids and synthetic analogues, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.0X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73610,"description":"Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.0X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73611,"description":"Adverse effect of glucocorticoids and synthetic analogues, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.1X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73635,"description":"Adverse effect of thyroid hormones and substitutes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.1X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73636,"description":"Adverse effect of thyroid hormones and substitutes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.1X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73637,"description":"Adverse effect of thyroid hormones and substitutes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.2X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73661,"description":"Adverse effect of antithyroid drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.2X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73662,"description":"Adverse effect of antithyroid drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.2X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73663,"description":"Adverse effect of antithyroid drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.6X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73765,"description":"Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.6X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73766,"description":"Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.6X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73767,"description":"Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.7X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73791,"description":"Adverse effect of androgens and anabolic congeners, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.7X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73792,"description":"Adverse effect of androgens and anabolic congeners, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.7X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73793,"description":"Adverse effect of androgens and anabolic congeners, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.805A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73817,"description":"Adverse effect of unspecified hormones and synthetic substitutes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.805D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73818,"description":"Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.805S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73819,"description":"Adverse effect of unspecified hormones and synthetic substitutes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.815A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73842,"description":"Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.815D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73843,"description":"Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.815S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73844,"description":"Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.895A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73867,"description":"Adverse effect of other hormones and synthetic substitutes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.895D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73868,"description":"Adverse effect of other hormones and synthetic substitutes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.895S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73869,"description":"Adverse effect of other hormones and synthetic substitutes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.905A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73893,"description":"Adverse effect of unspecified hormone antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.905D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73894,"description":"Adverse effect of unspecified hormone antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.905S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73895,"description":"Adverse effect of unspecified hormone antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.995A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":73918,"description":"Adverse effect of other hormone antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.995D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":73919,"description":"Adverse effect of other hormone antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.995S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":73920,"description":"Adverse effect of other hormone antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.1X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75372,"description":"Adverse effect of other parasympathomimetics [cholinergics], initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.1X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75373,"description":"Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.1X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75374,"description":"Adverse effect of other parasympathomimetics [cholinergics], sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.2X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75398,"description":"Adverse effect of ganglionic blocking drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.2X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75399,"description":"Adverse effect of ganglionic blocking drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.2X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75400,"description":"Adverse effect of ganglionic blocking drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.3X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75424,"description":"Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.3X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75425,"description":"Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.3X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75426,"description":"Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.4X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75450,"description":"Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.4X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75451,"description":"Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.4X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75452,"description":"Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.5X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75476,"description":"Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.5X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75477,"description":"Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.5X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75478,"description":"Adverse effect of predominantly beta-adrenoreceptor agonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.6X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75502,"description":"Adverse effect of alpha-adrenoreceptor antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.6X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75503,"description":"Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.6X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75504,"description":"Adverse effect of alpha-adrenoreceptor antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.7X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75528,"description":"Adverse effect of beta-adrenoreceptor antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.7X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75529,"description":"Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.7X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75530,"description":"Adverse effect of beta-adrenoreceptor antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.8X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75554,"description":"Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.8X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75555,"description":"Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.8X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75556,"description":"Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.905A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75580,"description":"Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.905D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75581,"description":"Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.905S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75582,"description":"Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.995A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75605,"description":"Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.995D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75606,"description":"Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.995S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75607,"description":"Adverse effect of other drug primarily affecting the autonomic nervous system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75658,"description":"Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75659,"description":"Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75660,"description":"Adverse effect of antineoplastic and immunosuppressive drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.0X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":75992,"description":"Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.0X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":75993,"description":"Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.0X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":75994,"description":"Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.1X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76018,"description":"Adverse effect of calcium-channel blockers, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.1X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76019,"description":"Adverse effect of calcium-channel blockers, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.1X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76020,"description":"Adverse effect of calcium-channel blockers, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.2X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76044,"description":"Adverse effect of other antidysrhythmic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.2X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76045,"description":"Adverse effect of other antidysrhythmic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.2X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76046,"description":"Adverse effect of other antidysrhythmic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.3X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76070,"description":"Adverse effect of coronary vasodilators, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.3X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76071,"description":"Adverse effect of coronary vasodilators, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.3X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76072,"description":"Adverse effect of coronary vasodilators, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.4X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76096,"description":"Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.4X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76097,"description":"Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.4X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76098,"description":"Adverse effect of angiotensin-converting-enzyme inhibitors, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.5X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76122,"description":"Adverse effect of other antihypertensive drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.5X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76123,"description":"Adverse effect of other antihypertensive drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.5X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76124,"description":"Adverse effect of other antihypertensive drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.6X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76148,"description":"Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.6X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76149,"description":"Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.6X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76150,"description":"Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.7X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76174,"description":"Adverse effect of peripheral vasodilators, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.7X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76175,"description":"Adverse effect of peripheral vasodilators, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.7X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76176,"description":"Adverse effect of peripheral vasodilators, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.8X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76200,"description":"Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.8X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76201,"description":"Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.8X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76202,"description":"Adverse effect of antivaricose drugs, including sclerosing agents, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.905A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76226,"description":"Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.905D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76227,"description":"Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.905S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76228,"description":"Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.995A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76251,"description":"Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.995D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76252,"description":"Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.995S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76253,"description":"Adverse effect of other agents primarily affecting the cardiovascular system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.0X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":76278,"description":"Adverse effect of histamine H2-receptor blockers, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.0X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":76279,"description":"Adverse effect of histamine H2-receptor blockers, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.0X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":76280,"description":"Adverse effect of histamine H2-receptor blockers, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.0X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":77057,"description":"Adverse effect of mineralocorticoids and their antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.0X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":77058,"description":"Adverse effect of mineralocorticoids and their antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.0X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":77059,"description":"Adverse effect of mineralocorticoids and their antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.1X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":77083,"description":"Adverse effect of loop [high-ceiling] diuretics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.1X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":77084,"description":"Adverse effect of loop [high-ceiling] diuretics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.1X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":77085,"description":"Adverse effect of loop [high-ceiling] diuretics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.2X5A","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"B","sort_order":77109,"description":"Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.2X5D","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"M","sort_order":77110,"description":"Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.2X5S","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"E","sort_order":77111,"description":"Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z08","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":92621,"description":"Encounter for follow-up examination after completed treatment for malignant neoplasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z09","icd10_code_version":5,"icd10_support_group":2,"asterisk":"N","range":"N","sort_order":92622,"description":"Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null}]},{"grp":3,"paragraph":null,"description":"Unstable angina","children":[{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.0","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":10863,"description":"Unstable angina","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.1","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10864,"description":"Angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.8","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10865,"description":"Other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.9","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":10866,"description":"Angina pectoris, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.0","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":10901,"description":"Acute coronary thrombosis not resulting in myocardial infarction","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.1","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10902,"description":"Dressler's syndrome","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.8","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10903,"description":"Other forms of acute ischemic heart disease","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.9","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":10904,"description":"Acute ischemic heart disease, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.10","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":10907,"description":"Atherosclerotic heart disease of native coronary artery without angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.110","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10909,"description":"Atherosclerotic heart disease of native coronary artery with unstable angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.111","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10910,"description":"Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.118","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10911,"description":"Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.119","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10912,"description":"Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.2","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10913,"description":"Old myocardial infarction","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.3","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10914,"description":"Aneurysm of heart","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.41","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10916,"description":"Coronary artery aneurysm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.42","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10917,"description":"Coronary artery dissection","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.5","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10918,"description":"Ischemic cardiomyopathy","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.6","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10919,"description":"Silent myocardial ischemia","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.700","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10922,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.701","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10923,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.708","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10924,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.709","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10925,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.710","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10927,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.711","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10928,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.718","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10929,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.719","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10930,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.720","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10932,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.721","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10933,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.728","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10934,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.729","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10935,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.730","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10937,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.731","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10938,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.738","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10939,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.739","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10940,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.750","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10942,"description":"Atherosclerosis of native coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.751","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10943,"description":"Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.758","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10944,"description":"Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.759","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10945,"description":"Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.760","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10947,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.761","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10948,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.768","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10949,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.769","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10950,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.790","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10952,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.791","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10953,"description":"Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.798","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10954,"description":"Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.799","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10955,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.810","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10958,"description":"Atherosclerosis of coronary artery bypass graft(s) without angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.811","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10959,"description":"Atherosclerosis of native coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.812","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10960,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.82","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10961,"description":"Chronic total occlusion of coronary artery","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.83","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10962,"description":"Coronary atherosclerosis due to lipid rich plaque","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.84","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10963,"description":"Coronary atherosclerosis due to calcified coronary lesion","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.89","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":10964,"description":"Other forms of chronic ischemic heart disease","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.9","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":10965,"description":"Chronic ischemic heart disease, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.0","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":11014,"description":"Nonrheumatic mitral (valve) insufficiency","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.1","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11015,"description":"Nonrheumatic mitral (valve) prolapse","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.2","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11016,"description":"Nonrheumatic mitral (valve) stenosis","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.8","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11017,"description":"Other nonrheumatic mitral valve disorders","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I34.9","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":11018,"description":"Nonrheumatic mitral valve disorder, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.30","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":11062,"description":"Unspecified atrioventricular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.39","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11063,"description":"Other atrioventricular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.4","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11064,"description":"Left anterior fascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.5","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11065,"description":"Left posterior fascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.60","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11067,"description":"Unspecified fascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.69","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11068,"description":"Other fascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.7","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11069,"description":"Left bundle-branch block, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.0","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11071,"description":"Right fascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.10","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11073,"description":"Unspecified right bundle-branch block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.19","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11074,"description":"Other right bundle-branch block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.2","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11075,"description":"Bifascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.3","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11076,"description":"Trifascicular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.4","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11077,"description":"Nonspecific intraventricular block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.5","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11078,"description":"Other specified heart block","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.6","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":11079,"description":"Pre-excitation syndrome","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.0","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":11094,"description":"Paroxysmal atrial fibrillation","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.2","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":11096,"description":"Chronic atrial fibrillation","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.91","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":11100,"description":"Unspecified atrial fibrillation","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.1","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":11116,"description":"Left ventricular failure, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.20","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11118,"description":"Unspecified systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.21","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11119,"description":"Acute systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.22","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11120,"description":"Chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.23","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11121,"description":"Acute on chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.30","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11123,"description":"Unspecified diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.31","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11124,"description":"Acute diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.32","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11125,"description":"Chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.33","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11126,"description":"Acute on chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.40","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11128,"description":"Unspecified combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.41","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11129,"description":"Acute combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.42","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11130,"description":"Chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.43","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11131,"description":"Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.810","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11134,"description":"Right heart failure, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.811","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11135,"description":"Acute right heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.812","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11136,"description":"Chronic right heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.813","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11137,"description":"Acute on chronic right heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.814","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11138,"description":"Right heart failure due to left heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.82","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11139,"description":"Biventricular heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.83","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11140,"description":"High output heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.84","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11141,"description":"End stage heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.89","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11142,"description":"Other heart failure","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.9","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":11143,"description":"Heart failure, unspecified","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.211","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":11668,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, right leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.212","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11669,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, left leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.213","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11670,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.218","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11671,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.219","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11672,"description":"Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.221","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11674,"description":"Atherosclerosis of native arteries of extremities with rest pain, right leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.222","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11675,"description":"Atherosclerosis of native arteries of extremities with rest pain, left leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.223","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11676,"description":"Atherosclerosis of native arteries of extremities with rest pain, bilateral legs","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.228","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11677,"description":"Atherosclerosis of native arteries of extremities with rest pain, other extremity","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.229","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11678,"description":"Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.231","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11680,"description":"Atherosclerosis of native arteries of right leg with ulceration of thigh","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.232","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11681,"description":"Atherosclerosis of native arteries of right leg with ulceration of calf","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.233","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11682,"description":"Atherosclerosis of native arteries of right leg with ulceration of ankle","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.234","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11683,"description":"Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.235","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11684,"description":"Atherosclerosis of native arteries of right leg with ulceration of other part of foot","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.238","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11685,"description":"Atherosclerosis of native arteries of right leg with ulceration of other part of lower right leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.239","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11686,"description":"Atherosclerosis of native arteries of right leg with ulceration of unspecified site","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.241","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11688,"description":"Atherosclerosis of native arteries of left leg with ulceration of thigh","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.242","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11689,"description":"Atherosclerosis of native arteries of left leg with ulceration of calf","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.243","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11690,"description":"Atherosclerosis of native arteries of left leg with ulceration of ankle","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.244","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11691,"description":"Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.245","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11692,"description":"Atherosclerosis of native arteries of left leg with ulceration of other part of foot","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.248","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11693,"description":"Atherosclerosis of native arteries of left leg with ulceration of other part of lower left leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.249","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11694,"description":"Atherosclerosis of native arteries of left leg with ulceration of unspecified site","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.25","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11695,"description":"Atherosclerosis of native arteries of other extremities with ulceration","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.261","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11697,"description":"Atherosclerosis of native arteries of extremities with gangrene, right leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.262","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11698,"description":"Atherosclerosis of native arteries of extremities with gangrene, left leg","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.263","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11699,"description":"Atherosclerosis of native arteries of extremities with gangrene, bilateral legs","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.268","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":11700,"description":"Atherosclerosis of native arteries of extremities with gangrene, other extremity","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.269","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":11701,"description":"Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I70.92","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":11952,"description":"Chronic total occlusion of artery of the extremities","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R94.31","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":29396,"description":"Abnormal electrocardiogram [ECG] [EKG]","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R94.39","icd10_code_version":5,"icd10_support_group":3,"asterisk":"Y","range":"N","sort_order":29397,"description":"Abnormal result of other cardiovascular function study","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73141,"description":"Adverse effect of penicillins, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73142,"description":"Adverse effect of penicillins, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73143,"description":"Adverse effect of penicillins, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73167,"description":"Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73168,"description":"Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73169,"description":"Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73193,"description":"Adverse effect of chloramphenicol group, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73194,"description":"Adverse effect of chloramphenicol group, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73195,"description":"Adverse effect of chloramphenicol group, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73219,"description":"Adverse effect of macrolides, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73220,"description":"Adverse effect of macrolides, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73221,"description":"Adverse effect of macrolides, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73245,"description":"Adverse effect of tetracyclines, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73246,"description":"Adverse effect of tetracyclines, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73247,"description":"Adverse effect of tetracyclines, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73271,"description":"Adverse effect of aminoglycosides, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73272,"description":"Adverse effect of aminoglycosides, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73273,"description":"Adverse effect of aminoglycosides, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73297,"description":"Adverse effect of rifampicins, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73298,"description":"Adverse effect of rifampicins, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73299,"description":"Adverse effect of rifampicins, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73323,"description":"Adverse effect of antifungal antibiotics, systemically used, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73324,"description":"Adverse effect of antifungal antibiotics, systemically used, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73325,"description":"Adverse effect of antifungal antibiotics, systemically used, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73349,"description":"Adverse effect of other systemic antibiotics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73350,"description":"Adverse effect of other systemic antibiotics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73351,"description":"Adverse effect of other systemic antibiotics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73374,"description":"Adverse effect of unspecified systemic antibiotic, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73375,"description":"Adverse effect of unspecified systemic antibiotic, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T36.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73376,"description":"Adverse effect of unspecified systemic antibiotic, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73401,"description":"Adverse effect of sulfonamides, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73402,"description":"Adverse effect of sulfonamides, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73403,"description":"Adverse effect of sulfonamides, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73427,"description":"Adverse effect of antimycobacterial drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73428,"description":"Adverse effect of antimycobacterial drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73429,"description":"Adverse effect of antimycobacterial drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73453,"description":"Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73454,"description":"Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73455,"description":"Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73479,"description":"Adverse effect of other antiprotozoal drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73480,"description":"Adverse effect of other antiprotozoal drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73481,"description":"Adverse effect of other antiprotozoal drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73505,"description":"Adverse effect of anthelminthics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73506,"description":"Adverse effect of anthelminthics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73507,"description":"Adverse effect of anthelminthics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73531,"description":"Adverse effect of antiviral drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73532,"description":"Adverse effect of antiviral drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73533,"description":"Adverse effect of antiviral drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73557,"description":"Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73558,"description":"Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73559,"description":"Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73582,"description":"Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73583,"description":"Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T37.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73584,"description":"Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73609,"description":"Adverse effect of glucocorticoids and synthetic analogues, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73610,"description":"Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73611,"description":"Adverse effect of glucocorticoids and synthetic analogues, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73635,"description":"Adverse effect of thyroid hormones and substitutes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73636,"description":"Adverse effect of thyroid hormones and substitutes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73637,"description":"Adverse effect of thyroid hormones and substitutes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73661,"description":"Adverse effect of antithyroid drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73662,"description":"Adverse effect of antithyroid drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73663,"description":"Adverse effect of antithyroid drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73713,"description":"Adverse effect of oral contraceptives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73714,"description":"Adverse effect of oral contraceptives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73715,"description":"Adverse effect of oral contraceptives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73739,"description":"Adverse effect of other estrogens and progestogens, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73740,"description":"Adverse effect of other estrogens and progestogens, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73741,"description":"Adverse effect of other estrogens and progestogens, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73765,"description":"Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73766,"description":"Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73767,"description":"Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73791,"description":"Adverse effect of androgens and anabolic congeners, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73792,"description":"Adverse effect of androgens and anabolic congeners, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73793,"description":"Adverse effect of androgens and anabolic congeners, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.805A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73817,"description":"Adverse effect of unspecified hormones and synthetic substitutes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.805D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73818,"description":"Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.805S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73819,"description":"Adverse effect of unspecified hormones and synthetic substitutes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.815A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73842,"description":"Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.815D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73843,"description":"Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.815S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73844,"description":"Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.895A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73867,"description":"Adverse effect of other hormones and synthetic substitutes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.895D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73868,"description":"Adverse effect of other hormones and synthetic substitutes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.895S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73869,"description":"Adverse effect of other hormones and synthetic substitutes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.905A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73893,"description":"Adverse effect of unspecified hormone antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.905D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73894,"description":"Adverse effect of unspecified hormone antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.905S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73895,"description":"Adverse effect of unspecified hormone antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.995A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73918,"description":"Adverse effect of other hormone antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.995D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73919,"description":"Adverse effect of other hormone antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T38.995S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73920,"description":"Adverse effect of other hormone antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.015A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73945,"description":"Adverse effect of aspirin, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.015D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73946,"description":"Adverse effect of aspirin, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.015S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73947,"description":"Adverse effect of aspirin, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.095A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73970,"description":"Adverse effect of salicylates, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.095D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73971,"description":"Adverse effect of salicylates, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.095S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73972,"description":"Adverse effect of salicylates, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":73996,"description":"Adverse effect of 4-Aminophenol derivatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":73997,"description":"Adverse effect of 4-Aminophenol derivatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":73998,"description":"Adverse effect of 4-Aminophenol derivatives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74022,"description":"Adverse effect of pyrazolone derivatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74023,"description":"Adverse effect of pyrazolone derivatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74024,"description":"Adverse effect of pyrazolone derivatives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.315A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74048,"description":"Adverse effect of propionic acid derivatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.315D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74049,"description":"Adverse effect of propionic acid derivatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.315S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74050,"description":"Adverse effect of propionic acid derivatives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.395A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74073,"description":"Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.395D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74074,"description":"Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.395S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74075,"description":"Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74099,"description":"Adverse effect of antirheumatics, not elsewhere classified, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74100,"description":"Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74101,"description":"Adverse effect of antirheumatics, not elsewhere classified, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74125,"description":"Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74126,"description":"Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74127,"description":"Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74150,"description":"Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74151,"description":"Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T39.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74152,"description":"Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74177,"description":"Adverse effect of opium, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74178,"description":"Adverse effect of opium, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74179,"description":"Adverse effect of opium, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74221,"description":"Adverse effect of other opioids, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74222,"description":"Adverse effect of other opioids, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74223,"description":"Adverse effect of other opioids, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74247,"description":"Adverse effect of methadone, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74248,"description":"Adverse effect of methadone, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74249,"description":"Adverse effect of methadone, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74273,"description":"Adverse effect of other synthetic narcotics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74274,"description":"Adverse effect of other synthetic narcotics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74275,"description":"Adverse effect of other synthetic narcotics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74299,"description":"Adverse effect of cocaine, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74300,"description":"Adverse effect of cocaine, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74301,"description":"Adverse effect of cocaine, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.605A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74325,"description":"Adverse effect of unspecified narcotics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.605D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74326,"description":"Adverse effect of unspecified narcotics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.605S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74327,"description":"Adverse effect of unspecified narcotics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.695A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74350,"description":"Adverse effect of other narcotics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.695D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74351,"description":"Adverse effect of other narcotics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.695S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74352,"description":"Adverse effect of other narcotics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74376,"description":"Adverse effect of cannabis (derivatives), initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74377,"description":"Adverse effect of cannabis (derivatives), subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74378,"description":"Adverse effect of cannabis (derivatives), sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.905A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74420,"description":"Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.905D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74421,"description":"Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.905S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74422,"description":"Adverse effect of unspecified psychodysleptics [hallucinogens], sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.995A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74445,"description":"Adverse effect of other psychodysleptics [hallucinogens], initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.995D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74446,"description":"Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T40.995S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74447,"description":"Adverse effect of other psychodysleptics [hallucinogens], sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T41.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74626,"description":"Adverse effect of therapeutic gases, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T41.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74627,"description":"Adverse effect of therapeutic gases, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T41.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74628,"description":"Adverse effect of therapeutic gases, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74653,"description":"Adverse effect of hydantoin derivatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74654,"description":"Adverse effect of hydantoin derivatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74655,"description":"Adverse effect of hydantoin derivatives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74679,"description":"Adverse effect of iminostilbenes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74680,"description":"Adverse effect of iminostilbenes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74681,"description":"Adverse effect of iminostilbenes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74705,"description":"Adverse effect of succinimides and oxazolidinediones, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74706,"description":"Adverse effect of succinimides and oxazolidinediones, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74707,"description":"Adverse effect of succinimides and oxazolidinediones, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74731,"description":"Adverse effect of barbiturates, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74732,"description":"Adverse effect of barbiturates, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74733,"description":"Adverse effect of barbiturates, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74757,"description":"Adverse effect of benzodiazepines, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74758,"description":"Adverse effect of benzodiazepines, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74759,"description":"Adverse effect of benzodiazepines, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74783,"description":"Adverse effect of mixed antiepileptics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74784,"description":"Adverse effect of mixed antiepileptics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74785,"description":"Adverse effect of mixed antiepileptics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74809,"description":"Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74810,"description":"Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74811,"description":"Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.75XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74834,"description":"Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.75XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74835,"description":"Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.75XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74836,"description":"Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74860,"description":"Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74861,"description":"Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T42.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74862,"description":"Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.015A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74887,"description":"Adverse effect of tricyclic antidepressants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.015D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74888,"description":"Adverse effect of tricyclic antidepressants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.015S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74889,"description":"Adverse effect of tricyclic antidepressants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.025A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74912,"description":"Adverse effect of tetracyclic antidepressants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.025D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74913,"description":"Adverse effect of tetracyclic antidepressants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.025S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74914,"description":"Adverse effect of tetracyclic antidepressants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74938,"description":"Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74939,"description":"Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74940,"description":"Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.205A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74964,"description":"Adverse effect of unspecified antidepressants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.205D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74965,"description":"Adverse effect of unspecified antidepressants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.205S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74966,"description":"Adverse effect of unspecified antidepressants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.215A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":74989,"description":"Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.215D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":74990,"description":"Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.215S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":74991,"description":"Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.225A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75014,"description":"Adverse effect of selective serotonin reuptake inhibitors, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.225D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75015,"description":"Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.225S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75016,"description":"Adverse effect of selective serotonin reuptake inhibitors, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.295A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75039,"description":"Adverse effect of other antidepressants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.295D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75040,"description":"Adverse effect of other antidepressants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.295S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75041,"description":"Adverse effect of other antidepressants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75065,"description":"Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75066,"description":"Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75067,"description":"Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75091,"description":"Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75092,"description":"Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75093,"description":"Adverse effect of butyrophenone and thiothixene neuroleptics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.505A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75117,"description":"Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.505D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75118,"description":"Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.505S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75119,"description":"Adverse effect of unspecified antipsychotics and neuroleptics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.595A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75142,"description":"Adverse effect of other antipsychotics and neuroleptics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.595D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75143,"description":"Adverse effect of other antipsychotics and neuroleptics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.595S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75144,"description":"Adverse effect of other antipsychotics and neuroleptics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.605A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75168,"description":"Adverse effect of unspecified psychostimulants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.605D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75169,"description":"Adverse effect of unspecified psychostimulants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.605S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75170,"description":"Adverse effect of unspecified psychostimulants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.615A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75193,"description":"Adverse effect of caffeine, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.615D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75194,"description":"Adverse effect of caffeine, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.615S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75195,"description":"Adverse effect of caffeine, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.625A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75218,"description":"Adverse effect of amphetamines, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.625D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75219,"description":"Adverse effect of amphetamines, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.625S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75220,"description":"Adverse effect of amphetamines, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.635A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75243,"description":"Adverse effect of methylphenidate, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.635D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75244,"description":"Adverse effect of methylphenidate, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.635S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75245,"description":"Adverse effect of methylphenidate, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.695A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75268,"description":"Adverse effect of other psychostimulants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.695D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75269,"description":"Adverse effect of other psychostimulants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.695S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75270,"description":"Adverse effect of other psychostimulants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75294,"description":"Adverse effect of other psychotropic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75295,"description":"Adverse effect of other psychotropic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75296,"description":"Adverse effect of other psychotropic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75319,"description":"Adverse effect of unspecified psychotropic drug, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75320,"description":"Adverse effect of unspecified psychotropic drug, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T43.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75321,"description":"Adverse effect of unspecified psychotropic drug, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75346,"description":"Adverse effect of anticholinesterase agents, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75347,"description":"Adverse effect of anticholinesterase agents, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75348,"description":"Adverse effect of anticholinesterase agents, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75372,"description":"Adverse effect of other parasympathomimetics [cholinergics], initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75373,"description":"Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75374,"description":"Adverse effect of other parasympathomimetics [cholinergics], sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75398,"description":"Adverse effect of ganglionic blocking drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75399,"description":"Adverse effect of ganglionic blocking drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75400,"description":"Adverse effect of ganglionic blocking drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75424,"description":"Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75425,"description":"Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75426,"description":"Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75450,"description":"Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75451,"description":"Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75452,"description":"Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75476,"description":"Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75477,"description":"Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75478,"description":"Adverse effect of predominantly beta-adrenoreceptor agonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75502,"description":"Adverse effect of alpha-adrenoreceptor antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75503,"description":"Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75504,"description":"Adverse effect of alpha-adrenoreceptor antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75528,"description":"Adverse effect of beta-adrenoreceptor antagonists, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75529,"description":"Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75530,"description":"Adverse effect of beta-adrenoreceptor antagonists, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75554,"description":"Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75555,"description":"Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75556,"description":"Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.905A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75580,"description":"Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.905D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75581,"description":"Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.905S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75582,"description":"Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.995A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75605,"description":"Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.995D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75606,"description":"Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T44.995S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75607,"description":"Adverse effect of other drug primarily affecting the autonomic nervous system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75632,"description":"Adverse effect of antiallergic and antiemetic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75633,"description":"Adverse effect of antiallergic and antiemetic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75634,"description":"Adverse effect of antiallergic and antiemetic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X1A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75642,"description":"Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X1D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75643,"description":"Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X1S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75644,"description":"Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75658,"description":"Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75659,"description":"Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75660,"description":"Adverse effect of antineoplastic and immunosuppressive drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75684,"description":"Adverse effect of vitamins, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75685,"description":"Adverse effect of vitamins, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75686,"description":"Adverse effect of vitamins, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75710,"description":"Adverse effect of enzymes, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75711,"description":"Adverse effect of enzymes, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75712,"description":"Adverse effect of enzymes, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75736,"description":"Adverse effect of iron and its compounds, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75737,"description":"Adverse effect of iron and its compounds, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75738,"description":"Adverse effect of iron and its compounds, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.515A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75762,"description":"Adverse effect of anticoagulants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.515D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75763,"description":"Adverse effect of anticoagulants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.515S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75764,"description":"Adverse effect of anticoagulants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.525A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75787,"description":"Adverse effect of antithrombotic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.525D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75788,"description":"Adverse effect of antithrombotic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.525S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75789,"description":"Adverse effect of antithrombotic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.605A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75813,"description":"Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.605D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75814,"description":"Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.605S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75815,"description":"Adverse effect of unspecified fibrinolysis-affecting drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.615A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75838,"description":"Adverse effect of thrombolytic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.615D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75839,"description":"Adverse effect of thrombolytic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.615S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75840,"description":"Adverse effect of thrombolytic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.625A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75863,"description":"Adverse effect of hemostatic drug, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.625D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75864,"description":"Adverse effect of hemostatic drug, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.625S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75865,"description":"Adverse effect of hemostatic drug, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.695A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75888,"description":"Adverse effect of other fibrinolysis-affecting drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.695D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75889,"description":"Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.695S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75890,"description":"Adverse effect of other fibrinolysis-affecting drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75914,"description":"Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75915,"description":"Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75916,"description":"Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75940,"description":"Adverse effect of other primarily systemic and hematological agents, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75941,"description":"Adverse effect of other primarily systemic and hematological agents, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75942,"description":"Adverse effect of other primarily systemic and hematological agents, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75965,"description":"Adverse effect of unspecified primarily systemic and hematological agent, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75966,"description":"Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T45.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75967,"description":"Adverse effect of unspecified primarily systemic and hematological agent, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":75992,"description":"Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":75993,"description":"Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":75994,"description":"Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76018,"description":"Adverse effect of calcium-channel blockers, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76019,"description":"Adverse effect of calcium-channel blockers, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76020,"description":"Adverse effect of calcium-channel blockers, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76044,"description":"Adverse effect of other antidysrhythmic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76045,"description":"Adverse effect of other antidysrhythmic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76046,"description":"Adverse effect of other antidysrhythmic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76070,"description":"Adverse effect of coronary vasodilators, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76071,"description":"Adverse effect of coronary vasodilators, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76072,"description":"Adverse effect of coronary vasodilators, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76096,"description":"Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76097,"description":"Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76098,"description":"Adverse effect of angiotensin-converting-enzyme inhibitors, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76122,"description":"Adverse effect of other antihypertensive drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76123,"description":"Adverse effect of other antihypertensive drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76124,"description":"Adverse effect of other antihypertensive drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76148,"description":"Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76149,"description":"Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76150,"description":"Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76174,"description":"Adverse effect of peripheral vasodilators, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76175,"description":"Adverse effect of peripheral vasodilators, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76176,"description":"Adverse effect of peripheral vasodilators, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76200,"description":"Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76201,"description":"Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76202,"description":"Adverse effect of antivaricose drugs, including sclerosing agents, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.905A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76226,"description":"Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.905D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76227,"description":"Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.905S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76228,"description":"Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.995A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76251,"description":"Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.995D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76252,"description":"Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T46.995S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76253,"description":"Adverse effect of other agents primarily affecting the cardiovascular system, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76278,"description":"Adverse effect of histamine H2-receptor blockers, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76279,"description":"Adverse effect of histamine H2-receptor blockers, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76280,"description":"Adverse effect of histamine H2-receptor blockers, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76304,"description":"Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76305,"description":"Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76306,"description":"Adverse effect of other antacids and anti-gastric-secretion drugs, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76330,"description":"Adverse effect of stimulant laxatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76331,"description":"Adverse effect of stimulant laxatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76332,"description":"Adverse effect of stimulant laxatives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76356,"description":"Adverse effect of saline and osmotic laxatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76357,"description":"Adverse effect of saline and osmotic laxatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76358,"description":"Adverse effect of saline and osmotic laxatives, sequela","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76382,"description":"Adverse effect of other laxatives, initial encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76383,"description":"Adverse effect of other laxatives, subsequent encounter","last_updated":"2017-09-22T17:27:28.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76384,"description":"Adverse effect of other laxatives, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76408,"description":"Adverse effect of digestants, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76409,"description":"Adverse effect of digestants, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76410,"description":"Adverse effect of digestants, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76434,"description":"Adverse effect of antidiarrheal drugs, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76435,"description":"Adverse effect of antidiarrheal drugs, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76436,"description":"Adverse effect of antidiarrheal drugs, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76460,"description":"Adverse effect of emetics, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76461,"description":"Adverse effect of emetics, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76462,"description":"Adverse effect of emetics, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76486,"description":"Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76487,"description":"Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76488,"description":"Adverse effect of other agents primarily affecting gastrointestinal system, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76511,"description":"Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76512,"description":"Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T47.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76513,"description":"Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76538,"description":"Adverse effect of oxytocic drugs, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76539,"description":"Adverse effect of oxytocic drugs, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76540,"description":"Adverse effect of oxytocic drugs, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76564,"description":"Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76565,"description":"Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76566,"description":"Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.205A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76590,"description":"Adverse effect of unspecified drugs acting on muscles, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.205D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76591,"description":"Adverse effect of unspecified drugs acting on muscles, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.205S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76592,"description":"Adverse effect of unspecified drugs acting on muscles, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.295A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76615,"description":"Adverse effect of other drugs acting on muscles, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.295D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76616,"description":"Adverse effect of other drugs acting on muscles, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.295S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76617,"description":"Adverse effect of other drugs acting on muscles, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76641,"description":"Adverse effect of antitussives, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76642,"description":"Adverse effect of antitussives, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76643,"description":"Adverse effect of antitussives, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76667,"description":"Adverse effect of expectorants, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76668,"description":"Adverse effect of expectorants, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76669,"description":"Adverse effect of expectorants, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76693,"description":"Adverse effect of other anti-common-cold drugs, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76694,"description":"Adverse effect of other anti-common-cold drugs, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76695,"description":"Adverse effect of other anti-common-cold drugs, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76719,"description":"Adverse effect of antiasthmatics, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76720,"description":"Adverse effect of antiasthmatics, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76721,"description":"Adverse effect of antiasthmatics, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.905A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76745,"description":"Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.905D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76746,"description":"Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.905S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76747,"description":"Adverse effect of unspecified agents primarily acting on the respiratory system, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.995A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76770,"description":"Adverse effect of other agents primarily acting on the respiratory system, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.995D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76771,"description":"Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T48.995S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76772,"description":"Adverse effect of other agents primarily acting on the respiratory system, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76797,"description":"Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76798,"description":"Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76799,"description":"Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76823,"description":"Adverse effect of antipruritics, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76824,"description":"Adverse effect of antipruritics, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76825,"description":"Adverse effect of antipruritics, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76849,"description":"Adverse effect of local astringents and local detergents, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76850,"description":"Adverse effect of local astringents and local detergents, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76851,"description":"Adverse effect of local astringents and local detergents, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76875,"description":"Adverse effect of emollients, demulcents and protectants, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76876,"description":"Adverse effect of emollients, demulcents and protectants, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76877,"description":"Adverse effect of emollients, demulcents and protectants, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76901,"description":"Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76902,"description":"Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76903,"description":"Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76927,"description":"Adverse effect of ophthalmological drugs and preparations, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76928,"description":"Adverse effect of ophthalmological drugs and preparations, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76929,"description":"Adverse effect of ophthalmological drugs and preparations, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76953,"description":"Adverse effect of otorhinolaryngological drugs and preparations, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76954,"description":"Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76955,"description":"Adverse effect of otorhinolaryngological drugs and preparations, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":76979,"description":"Adverse effect of dental drugs, topically applied, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":76980,"description":"Adverse effect of dental drugs, topically applied, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":76981,"description":"Adverse effect of dental drugs, topically applied, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77005,"description":"Adverse effect of other topical agents, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77006,"description":"Adverse effect of other topical agents, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77007,"description":"Adverse effect of other topical agents, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.95XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77030,"description":"Adverse effect of unspecified topical agent, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.95XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77031,"description":"Adverse effect of unspecified topical agent, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T49.95XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77032,"description":"Adverse effect of unspecified topical agent, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.0X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77057,"description":"Adverse effect of mineralocorticoids and their antagonists, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.0X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77058,"description":"Adverse effect of mineralocorticoids and their antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.0X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77059,"description":"Adverse effect of mineralocorticoids and their antagonists, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.1X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77083,"description":"Adverse effect of loop [high-ceiling] diuretics, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.1X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77084,"description":"Adverse effect of loop [high-ceiling] diuretics, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.1X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77085,"description":"Adverse effect of loop [high-ceiling] diuretics, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.2X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77109,"description":"Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.2X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77110,"description":"Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.2X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77111,"description":"Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.3X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77135,"description":"Adverse effect of electrolytic, caloric and water-balance agents, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.3X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77136,"description":"Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.3X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77137,"description":"Adverse effect of electrolytic, caloric and water-balance agents, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.4X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77161,"description":"Adverse effect of drugs affecting uric acid metabolism, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.4X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77162,"description":"Adverse effect of drugs affecting uric acid metabolism, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.4X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77163,"description":"Adverse effect of drugs affecting uric acid metabolism, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.5X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77187,"description":"Adverse effect of appetite depressants, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.5X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77188,"description":"Adverse effect of appetite depressants, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.5X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77189,"description":"Adverse effect of appetite depressants, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.6X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77213,"description":"Adverse effect of antidotes and chelating agents, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.6X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77214,"description":"Adverse effect of antidotes and chelating agents, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.6X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77215,"description":"Adverse effect of antidotes and chelating agents, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.7X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77239,"description":"Adverse effect of analeptics and opioid receptor antagonists, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.7X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77240,"description":"Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.7X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77241,"description":"Adverse effect of analeptics and opioid receptor antagonists, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.8X5A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77265,"description":"Adverse effect of diagnostic agents, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.8X5D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77266,"description":"Adverse effect of diagnostic agents, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.8X5S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77267,"description":"Adverse effect of diagnostic agents, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.905A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77469,"description":"Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.905D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77470,"description":"Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.905S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77471,"description":"Adverse effect of unspecified drugs, medicaments and biological substances, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.995A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77494,"description":"Adverse effect of other drugs, medicaments and biological substances, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.995D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77495,"description":"Adverse effect of other drugs, medicaments and biological substances, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.995S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77496,"description":"Adverse effect of other drugs, medicaments and biological substances, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A15A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77291,"description":"Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A15D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77292,"description":"Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A15S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77293,"description":"Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A25A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77316,"description":"Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A25D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77317,"description":"Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A25S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77318,"description":"Adverse effect of mixed bacterial vaccines without a pertussis component, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A95A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77341,"description":"Adverse effect of other bacterial vaccines, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A95D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77342,"description":"Adverse effect of other bacterial vaccines, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.A95S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77343,"description":"Adverse effect of other bacterial vaccines, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.B15A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77367,"description":"Adverse effect of smallpox vaccines, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.B15D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77368,"description":"Adverse effect of smallpox vaccines, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.B15S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77369,"description":"Adverse effect of smallpox vaccines, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.B95A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77392,"description":"Adverse effect of other viral vaccines, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.B95D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77393,"description":"Adverse effect of other viral vaccines, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.B95S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77394,"description":"Adverse effect of other viral vaccines, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.Z15A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77418,"description":"Adverse effect of immunoglobulin, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.Z15D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77419,"description":"Adverse effect of immunoglobulin, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.Z15S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77420,"description":"Adverse effect of immunoglobulin, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.Z95A","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":77443,"description":"Adverse effect of other vaccines and biological substances, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.Z95D","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":77444,"description":"Adverse effect of other vaccines and biological substances, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T50.Z95S","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":77445,"description":"Adverse effect of other vaccines and biological substances, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T88.52XA","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"B","sort_order":82790,"description":"Failed moderate sedation during procedure, initial encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T88.52XD","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"M","sort_order":82791,"description":"Failed moderate sedation during procedure, subsequent encounter","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"T88.52XS","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"E","sort_order":82792,"description":"Failed moderate sedation during procedure, sequela","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z01.810","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":92552,"description":"Encounter for preprocedural cardiovascular examination","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z08","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":92621,"description":"Encounter for follow-up examination after completed treatment for malignant neoplasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z09","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":92622,"description":"Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z79.3","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":93535,"description":"Long term (current) use of hormonal contraceptives","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z79.891","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":93550,"description":"Long term (current) use of opiate analgesic","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"Z79.899","icd10_code_version":5,"icd10_support_group":3,"asterisk":"N","range":"N","sort_order":93551,"description":"Other long term (current) drug therapy","last_updated":"2017-09-22T17:27:29.000Z","paragraph":null}]},{"grp":4,"paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>","description":"Sarcoid myocarditis","children":[{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"D86.85","icd10_code_version":5,"icd10_support_group":4,"asterisk":"Y","range":"N","sort_order":3626,"description":"Sarcoid myocarditis","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"D86.9","icd10_code_version":5,"icd10_support_group":4,"asterisk":"Y","range":"N","sort_order":3630,"description":"Sarcoidosis, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.1","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"B","sort_order":10864,"description":"Angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.8","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10865,"description":"Other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I20.9","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"E","sort_order":10866,"description":"Angina pectoris, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.0","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"N","sort_order":10901,"description":"Acute coronary thrombosis not resulting in myocardial infarction","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I24.1","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"N","sort_order":10902,"description":"Dressler's syndrome","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.10","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"B","sort_order":10907,"description":"Atherosclerotic heart disease of native coronary artery without angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.110","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10909,"description":"Atherosclerotic heart disease of native coronary artery with unstable angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.111","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10910,"description":"Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.118","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10911,"description":"Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.119","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"E","sort_order":10912,"description":"Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.3","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"B","sort_order":10914,"description":"Aneurysm of heart","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.41","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10916,"description":"Coronary artery aneurysm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.42","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"E","sort_order":10917,"description":"Coronary artery dissection","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.700","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"B","sort_order":10922,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.701","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10923,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.708","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10924,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.709","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10925,"description":"Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.710","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10927,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.711","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10928,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.718","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10929,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.719","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10930,"description":"Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.720","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10932,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.721","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10933,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.728","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10934,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.729","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10935,"description":"Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.730","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10937,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.731","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10938,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.738","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10939,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.739","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10940,"description":"Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.750","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10942,"description":"Atherosclerosis of native coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.751","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10943,"description":"Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.758","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10944,"description":"Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.759","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10945,"description":"Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.760","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10947,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.761","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10948,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.768","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10949,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.769","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10950,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.790","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10952,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.791","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10953,"description":"Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.798","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10954,"description":"Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.799","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10955,"description":"Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.810","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10958,"description":"Atherosclerosis of coronary artery bypass graft(s) without angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.811","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":10959,"description":"Atherosclerosis of native coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I25.812","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"E","sort_order":10960,"description":"Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I43","icd10_code_version":5,"icd10_support_group":4,"asterisk":"Y","range":"N","sort_order":11056,"description":"Cardiomyopathy in diseases classified elsewhere","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.30","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"B","sort_order":11062,"description":"Unspecified atrioventricular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.39","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11063,"description":"Other atrioventricular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.4","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11064,"description":"Left anterior fascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.5","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11065,"description":"Left posterior fascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.60","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11067,"description":"Unspecified fascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.69","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11068,"description":"Other fascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I44.7","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11069,"description":"Left bundle-branch block, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.0","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11071,"description":"Right fascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.10","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11073,"description":"Unspecified right bundle-branch block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.19","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11074,"description":"Other right bundle-branch block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.2","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11075,"description":"Bifascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.3","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11076,"description":"Trifascicular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.4","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11077,"description":"Nonspecific intraventricular block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I45.5","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"E","sort_order":11078,"description":"Other specified heart block","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.0","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"N","sort_order":11094,"description":"Paroxysmal atrial fibrillation","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.2","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"N","sort_order":11096,"description":"Chronic atrial fibrillation","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I48.91","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"N","sort_order":11100,"description":"Unspecified atrial fibrillation","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.1","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"B","sort_order":11116,"description":"Left ventricular failure, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.20","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11118,"description":"Unspecified systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.21","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11119,"description":"Acute systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.22","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11120,"description":"Chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.23","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11121,"description":"Acute on chronic systolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.30","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11123,"description":"Unspecified diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.31","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11124,"description":"Acute diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.32","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11125,"description":"Chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.33","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11126,"description":"Acute on chronic diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.40","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11128,"description":"Unspecified combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.41","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11129,"description":"Acute combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.42","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11130,"description":"Chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.43","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11131,"description":"Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.810","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11134,"description":"Right heart failure, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.811","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11135,"description":"Acute right heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.812","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11136,"description":"Chronic right heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.813","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11137,"description":"Acute on chronic right heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.814","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11138,"description":"Right heart failure due to left heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.82","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11139,"description":"Biventricular heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.83","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11140,"description":"High output heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.84","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11141,"description":"End stage heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.89","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"M","sort_order":11142,"description":"Other heart failure","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"I50.9","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"E","sort_order":11143,"description":"Heart failure, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"},{"lcd_id":36209,"lcd_version":15,"icd10_code_id":"R07.9","icd10_code_version":5,"icd10_support_group":4,"asterisk":"N","range":"N","sort_order":28580,"description":"Chest pain, unspecified","last_updated":"2017-09-22T17:27:29.000Z","paragraph":"<p>The following ICD-10 codes are applicable to Procedure codes 78459, 78491, and 78492 only:</p>"}]}],"revisionHistory":[{"lcd_id":36209,"lcd_version":15,"rev_hist_num":5,"rev_hist_date":"2017-10-01T00:00:00.000Z","rev_hist_exp":"<p><strong> Revision Number: 3</strong></p><p>Publication: September 2017 Connection&nbsp;</p><p>LCR A/B2017-038&nbsp;</p><p><strong> Explanation of Revision:</strong> Based on CR 10153 (Annual 2018 ICD-10-CM Update) the LCD was revised. Descriptor revised for ICD-10-CM diagnosis code I50.1.&nbsp; Added ICD-10-CM diagnosis code I21.9, I21.A1 &ndash; I21.A9 for procedure codes 93015, 93016, 93017, 93018. The effective date of this revision is based on date of service.</p><p>&nbsp;</p><p>10/01/2017:&nbsp; At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice.&nbsp; This revision is not a restriction to the coverage determination and therefore not all the fields included on the LCD are applicable as noted in this policy.</p>","last_updated":"2017-09-22T17:27:29.000Z"},{"lcd_id":36209,"lcd_version":10,"rev_hist_num":4,"rev_hist_date":"2017-03-23T00:00:00.000Z","rev_hist_exp":"Revision History Number: R2<br />Revision Number: 2<br />Publication: April 2017 Connection<br />LCR A/B2017-009<br /><br />Explanation of revision:  LCD was revised to add ICD-10-CM diagnosis code Z01.810 in the �ICD-10 Codes that Support Medical Necessity� section of the LCD for CPT codes 78451, 78452, 78453 and 78454. The effective date of this revision is for claims processed on or after 03/23/2017, for dates of service on or after 10/01/15.<br />","last_updated":"2017-03-23T14:11:49.000Z"},{"lcd_id":36209,"lcd_version":9,"rev_hist_num":3,"rev_hist_date":"2015-10-01T00:00:00.000Z","rev_hist_exp":"10/28/15- Added ICD-10 codes; I05.0- I05.9, I06.0- I06.9, I07.0- I07.9, I08.0- I08.9, I09.1 ,I09.81 ,<br />I09.89 ,I09.9 ,I35.0- I35.9, I36.0- I36.9,I37.0- I37.9\t \t<br /><br />","last_updated":"2015-10-28T11:45:24.000Z"},{"lcd_id":36209,"lcd_version":7,"rev_hist_num":2,"rev_hist_date":"2015-10-01T00:00:00.000Z","rev_hist_exp":"7/28/19- Paragraph information added to  ICD-10 code group four.","last_updated":"2015-07-28T16:33:29.000Z"},{"lcd_id":36209,"lcd_version":6,"rev_hist_num":1,"rev_hist_date":"2015-10-01T00:00:00.000Z","rev_hist_exp":" 2/17/15 - The language and/or ICD-10-CM diagnoses were updated to be consistent with the current ICD-9-CM LCD�s language and coding.","last_updated":"2015-07-17T16:09:37.000Z"}]}